<?xml version="1.0" encoding="UTF-8"?>
<archetype xmlns="http://schemas.openehr.org/v1" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <original_language>
    <terminology_id>
      <value>ISO_639-1</value>
    </terminology_id>
    <code_string>en</code_string>
  </original_language>
  <is_controlled>false</is_controlled>
  <description>
    <original_author id="date">2018-06-07</original_author>
    <original_author id="name">Silje Ljosland Bakke</original_author>
    <original_author id="organisation">Nasjonal IKT HF</original_author>
    <original_author id="email">silje.ljosland.bakke@nasjonalikt.no</original_author>
    <other_contributors>Morten Aas, Oslo Universitetssykehus, Norway</other_contributors>
    <other_contributors>Vebjørn Arntzen, Oslo University Hospital, Norway (openEHR Editor)</other_contributors>
    <other_contributors>Silje Ljosland Bakke, Helse Vest IKT AS, Norway (openEHR Editor)</other_contributors>
    <other_contributors>John Bennett, NEHTA, Australia</other_contributors>
    <other_contributors>SB Bhattacharyya, Bhattacharyyas Clinical Records Research &amp; Informatics LLP, India</other_contributors>
    <other_contributors>Sharmila Biswas, Australia</other_contributors>
    <other_contributors>Laila Bruun, Oslo universitetssykehus HF, Norway</other_contributors>
    <other_contributors>Stephen Chu, NEHTA, Australia (Editor)</other_contributors>
    <other_contributors>Matthew Cordell, NEHTA, Australia</other_contributors>
    <other_contributors>Duncan Cripps, University Hospitals Plmyouth NHS Trust, United Kingdom</other_contributors>
    <other_contributors>Lisbeth Dahlhaug, Helse Midt - Norge IT, Norway</other_contributors>
    <other_contributors>Gail Easterbrook, Flinders Medical Centre, Australia</other_contributors>
    <other_contributors>Stig Erik Hegrestad, Helse Førde, Norway</other_contributors>
    <other_contributors>David Evans, Queensland Health, Australia</other_contributors>
    <other_contributors>Sarah Gaunt, NEHTA, Australia</other_contributors>
    <other_contributors>Heather Grain, Llewelyn Grain Informatics, Australia</other_contributors>
    <other_contributors>Trina Gregory, cpc, Australia</other_contributors>
    <other_contributors>Sam Heard, Ocean Health Systems, Australia</other_contributors>
    <other_contributors>Hilde Hollås, DIPS AS, Norway</other_contributors>
    <other_contributors>Roar Holm, Helse Vest IKT A/S, Norway</other_contributors>
    <other_contributors>Alfred Honore, Haukeland, Norway</other_contributors>
    <other_contributors>Evelyn Hovenga, EJSH Consulting, Australia</other_contributors>
    <other_contributors>Lars Ivar Mehlum, Helse Bergen HF, Norway</other_contributors>
    <other_contributors>Patrícia Ivo, Prefeitura Municipal de Fortaleza, Brazil</other_contributors>
    <other_contributors>Tom Jarl Jakobsen, Helse Bergen, Norway</other_contributors>
    <other_contributors>Mary Kelaher, NEHTA, Australia</other_contributors>
    <other_contributors>Nils Kolstrup, Skansen Legekontor og Nasjonalt Senter for samhandling og telemedisin, Norway</other_contributors>
    <other_contributors>Harmony Kosola, Alberta Health Services, Canada</other_contributors>
    <other_contributors>Robert L'egan, NEHTA, Australia</other_contributors>
    <other_contributors>Mitja Lapajne, Marand, Slovenia</other_contributors>
    <other_contributors>Anette Larsson, Tieto Sweden AB, Sweden</other_contributors>
    <other_contributors>Heather Leslie, Atomica Informatics, Australia (openEHR Editor)</other_contributors>
    <other_contributors>Mark Luciani, Bath and North East Somerset, Swindon and Wiltshire Clinical Commisioning Group, United Kingdom</other_contributors>
    <other_contributors>Colin Macfarlane, Elsevier, United Kingdom</other_contributors>
    <other_contributors>Siv Marie Lien, DIPS ASA, Norway</other_contributors>
    <other_contributors>James McClay, University of Nebraska Medical Center, United States</other_contributors>
    <other_contributors>Susan McIndoe, Royal District Nursing Service, Australia</other_contributors>
    <other_contributors>David McKillop, NEHTA, Australia</other_contributors>
    <other_contributors>Hildegard McNicoll, freshEHR Clinical Informatics Ltd., United Kingdom</other_contributors>
    <other_contributors>Ian McNicoll, freshEHR Clinical Informatics, United Kingdom (openEHR Editor)</other_contributors>
    <other_contributors>Chris Mitchell, RACGP, Australia</other_contributors>
    <other_contributors>Stewart Morrison, NEHTA, Australia</other_contributors>
    <other_contributors>Andrej Orel, Marand d.o.o., Slovenia</other_contributors>
    <other_contributors>doug pankoski, Alberta Health Services, Canada</other_contributors>
    <other_contributors>Chris Pearce, Melbourne East GP Network, Australia</other_contributors>
    <other_contributors>Vladimir Pizzo, Clínica Parente Pizzo, Finland</other_contributors>
    <other_contributors>Camilla Preeston, Royal Australian College of General Practitioners, Australia</other_contributors>
    <other_contributors>Margaret Prichard, NEHTA, Australia</other_contributors>
    <other_contributors>Cathy Richardson, NEHTA, Australia</other_contributors>
    <other_contributors>Robyn Richards, NEHTA - Clinical Terminology, Australia</other_contributors>
    <other_contributors>Jussara Rotzsch, Hospital Alemão Oswaldo Cruz, Brazil</other_contributors>
    <other_contributors>Martha Schei Hynne, The Norwegian Medicines Agency, Norway</other_contributors>
    <other_contributors>Jason Scott, Plymouth Hospitals NHS Trust, United Kingdom</other_contributors>
    <other_contributors>Anoop Shah, University College London, United Kingdom</other_contributors>
    <other_contributors>Line Silsand, Universitetssykehuset i Nord-Norge, Norway</other_contributors>
    <other_contributors>Trine Strand, Oslo Universitetssykehus (OUS), Norway</other_contributors>
    <other_contributors>Norwegian Review Summary, Nasjonal IKT HF, Norway</other_contributors>
    <other_contributors>Andreas Sundstrom, Capio S:t Gorans Hospital, Sweden</other_contributors>
    <other_contributors>John Taylor, NEHTA, Australia</other_contributors>
    <other_contributors>Rowan Thomas, St. Vincent's Hospital Melbourne, Australia</other_contributors>
    <other_contributors>Richard Townley-O'Neill, NEHTA, Australia (Editor)</other_contributors>
    <other_contributors>Guri Tømmervåg, DIPS AS, Norway</other_contributors>
    <other_contributors>Gro-Hilde Ulriksen, Norwegian center for ehealthresearch, Norway</other_contributors>
    <other_contributors>John Tore Valand, Helse Bergen, Norway (openEHR Editor)</other_contributors>
    <other_contributors>Pelle Viana Lindén, Capio, Sweden</other_contributors>
    <other_contributors>Kylie Young, The Royal Australian College of General Practitioners, Australia</other_contributors>
    <lifecycle_state>published</lifecycle_state>
    <other_details id="licence">This work is licensed under the Creative Commons Attribution-ShareAlike 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by-sa/4.0/.</other_details>
    <other_details id="custodian_organisation">openEHR Foundation</other_details>
    <other_details id="references">ISO 11238:2018, Health informatics -- Identification of medicinal products -- Data elements and structures for the unique identification and exchange of regulated information on substances. Available from: https://www.iso.org/standard/69697.html.&#xD;
&#xD;
ISO 11239:2012, Health informatics -- Identification of medicinal products -- Data elements and structures for the unique identification and exchange of regulated information on pharmaceutical dose forms, units of presentation, routes of administration and packaging. Available from: https://www.iso.org/standard/55032.html.&#xD;
&#xD;
ISO 11240:2012, Health informatics -- Identification of medicinal products -- Data elements and structures for the unique identification and exchange of units of measurement. Available from: https://www.iso.org/standard/55033.html.&#xD;
&#xD;
ISO 11616:2017, Health informatics -- Identification of medicinal products -- Data elements and structures for unique identification and exchange of regulated pharmaceutical product information. Available from: https://www.iso.org/standard/70044.html.&#xD;
&#xD;
ISO 11615:2017, Health informatics -- Identification of medicinal products -- Data elements and structures for the unique identification and exchange of regulated medicinal product information. Available from: https://www.iso.org/standard/70150.html.&#xD;
&#xD;
FHIR Resource Medication, HL7 [Internet]. Available at: https://www.hl7.org/fhir/medication.html (Accessed 12 April 2018)</other_details>
    <other_details id="original_namespace">org.openehr</other_details>
    <other_details id="original_publisher">openEHR Foundation</other_details>
    <other_details id="custodian_namespace">org.openehr</other_details>
    <other_details id="MD5-CAM-1.0.1">2A670559F0806B97922C78743A81BC46</other_details>
    <other_details id="build_uid">c3c8a7ff-8fce-4e05-aed1-fb99dccaa3df</other_details>
    <other_details id="revision">2.0.6</other_details>
    <details>
      <language>
        <terminology_id>
          <value>ISO_639-1</value>
        </terminology_id>
        <code_string>de</code_string>
      </language>
      <purpose>Zur Darstellung von Details eines Arzneimittels oder einer Komponente eines Arzneimittels, einschließlich der Wirkstärke, der Darreichungsform und den Details über bestimmte Inhaltsstoffe.</purpose>
      <keywords>Arzneimittel</keywords>
      <keywords>Medikament</keywords>
      <keywords>Verordnung</keywords>
      <keywords>Verschreibung</keywords>
      <keywords>Rezept</keywords>
      <keywords>ein Rezept ausstellen</keywords>
      <keywords>Therapie</keywords>
      <keywords>Substanz</keywords>
      <keywords>Stoff</keywords>
      <keywords>Arznei</keywords>
      <keywords>Therapeutikum</keywords>
      <keywords>Wirkstoff</keywords>
      <keywords>Heilmittel</keywords>
      <keywords>ad-hoc</keywords>
      <keywords>ad hoc</keywords>
      <keywords>Rezeptur</keywords>
      <keywords>Zusammensetzung</keywords>
      <keywords>Medizin</keywords>
      <keywords>Pharmakon</keywords>
      <use>Zur Darstellung von Angaben zu einem Arzneimittel oder einer Arzneimittelkomponente, einschließlich der Wirkstärke, der Darreichungsform und den Angaben über spezielle Inhaltsstoffe.&#xD;
&#xD;
Dieser Archetyp soll für die Darstellung von Angaben zu einem Arzneimittel oder einer Arzneimittelkomponente verwendet werden. Dabei sollen vor allem die Darreichungsform und die Inhaltsstoffe detailliert beschrieben werden, z.B. zu einer Infusion oder einer Ad-hoc-Mixtur oder wenn es zu einem Arzneimittel keine Terminologie zur Verfügung steht. Im Rahmen einer Verordnung oder Abgabe eines Arzneimittels kann dieser Archetyp in den SLOT "Arzneimitteldetails" innerhalb des INSTRUCTION.medication_order Archetyps eingebettet werden. Für die Darstellung einer gegenwärtigen Verabreichung, Abgabe oder Anwendung eines Arzneimittels muss dieser Archetyp innerhalb des SLOTs "Arzneimitteldetails" in den Archetyp ACTION.medication eingefügt werden.&#xD;
&#xD;
Dieser Archetyp kann überflüssig sein, wenn die Verordnung eines verschreibungsfähigen Arzneimittels eine Terminologie zur Identifizierung des Arzneimittelproduktes verwendet. In diesem Fall kann der Marken- oder Produktname Informationen über die Darreichungsform und die Wirkstärke der Stoffe beinhalten.</use>
      <misuse>Nicht für die Kontrolle des Apothekenbestands oder zur Verwaltung von Arzneimittellisten verwenden.&#xD;
&#xD;
Nicht zur Darstellung einer beabsichtigten oder verabreichten Dosis eines Arzneimittels einsetzen. Für diesen Zweck müssen die Archetypen INSTRUCTION.medication_order oder CLUSTER.dosage verwendet werden.&#xD;
&#xD;
Darf nicht allein zum Ausfüllen einer Medikamentenliste verwendet werden. Verwenden Sie dazu einen relevanten medikamentenbezogenen ENTRY-Archetyp wie INSTRUCTION.medication_order oder ACTION.medication.</misuse>
      <copyright />
    </details>
    <details>
      <language>
        <terminology_id>
          <value>ISO_639-1</value>
        </terminology_id>
        <code_string>sv</code_string>
      </language>
      <purpose>Att registrera detaljer om en läkemedelsprodukt eller ett läkemedels innehållsämne, inklusive styrka, beredning och detaljer för specifika beståndsdelar.</purpose>
      <keywords>läkemedel</keywords>
      <keywords>ordinera</keywords>
      <keywords>ordination</keywords>
      <keywords>förskriva</keywords>
      <keywords>förskrivning</keywords>
      <keywords>läkemedelsordination</keywords>
      <keywords>läkemedelsförskrivning</keywords>
      <keywords>läkemedelsbehandling</keywords>
      <keywords>terapi</keywords>
      <keywords>substans</keywords>
      <keywords>läkemedel</keywords>
      <keywords>behandlingsavsikt</keywords>
      <keywords>terapeutisk</keywords>
      <keywords>ad-hoc</keywords>
      <keywords>adhoc</keywords>
      <keywords>ad hoc</keywords>
      <keywords>extempore</keywords>
      <keywords>extemporeläkemedel</keywords>
      <keywords>läkemedelsform</keywords>
      <keywords>läkemedelsberedning</keywords>
      <keywords>farmaceutisk produkt</keywords>
      <use>Används för att registrera detaljer om en läkemedelsprodukt eller ett läkemedels innehållsämne, inkluderande styrka, beredning och detaljer för specifika beståndsdelar.&#xD;
&#xD;
Denna arketyp ska användas för att registrera detaljer om ett läkemedel eller ett innehållsämne där beredning och enskilda beståndsdelar i läkemedlet behöver specificeras, till exempel vid infusioner, beredningar, extemporeläkemedel, eller om det inte finns medicinsk terminologi för att beskriva läkemedlet eller innehållsämnet. &#xD;
&#xD;
Vid ordination eller förskrivning av läkemedel, kan denna arketyp nästlas i SLOT "Medication details" i arketypen INSTRUCTION.medication_order. Vid registrering av administreringen eller expedieringen av läkemedel, kan denna arketyp nästlas i SLOT "Medication details" i arketypen ACTION.medication.&#xD;
&#xD;
Delar av denna arketyp kan vara redundanta om arketypen INSTRUCTION.medication_order använder en terminologi som identifierar läkemedlet. I så fall kan varumärket eller produktnamnet identifiera den aktiva substansens beredning och styrka.</use>
      <misuse>Ska inte användas för att kontrollera lager på apotek eller inom läkemedelskataloger.&#xD;
&#xD;
Ska inte användas för att registrera den avsedda eller administrerade dosen av ett läkemedel. Använd i stället någon av arketyperna INSTRUCTION.medication_order eller CLUSTER.dosage.&#xD;
&#xD;
Ska inte användas ensamt för att i fylla en läkemedelslista. Använd i stället en relevant läkemedelsrelaterad ENTRY-arketyp, t.ex. INSTRUCTION.medication_order eller ACTION.medication.</misuse>
      <copyright />
    </details>
    <details>
      <language>
        <terminology_id>
          <value>ISO_639-1</value>
        </terminology_id>
        <code_string>pt</code_string>
      </language>
      <purpose>Para registrar detalhes de uma preparação de medicamentos, incluindo, quando necessário, detalhes de múltiplos ingredientes, no contexto de uma infusão ou preparação ad-hoc (manipulada). A maioria das prescrições baseadas em dose terá sua precisa preparação determinada pelo estoque disponível na unidade, ou pelo fornecimento de farmácia, enquanto que, com a prescrição baseada em produtos, o nome da medicação traz detalhes da forma e concentração da preparação.</purpose>
      <keywords>medicação</keywords>
      <keywords>ordem</keywords>
      <keywords>prescrever</keywords>
      <keywords>terapia</keywords>
      <keywords>substância</keywords>
      <keywords>droga</keywords>
      <keywords>terapêutico</keywords>
      <keywords>venda livre</keywords>
      <keywords>ítem terapêutico</keywords>
      <keywords>Ad hoc</keywords>
      <keywords>manipulados</keywords>
      <use>*Use to record details about a medication or component of a medication, including strength, form and details of any specific constituents.&#xD;
&#xD;
This archetype is intended to be used to record details of a medication or component of a medication where the form and detailed ingredients of the medication need to be specified in more detail, for example, infusions and ad hoc mixtures, or where there is no medication terminology available. In the context of an order for administration or dispensing of a medication, nest this archetype within the Preparation details SLOT within the INSTRUCTION.medication_order archetype. In the context of recording the actual administration or dispensing or a medication, nest this archetype within the 'Medication details' SLOT within the ACTION.medication archetype.&#xD;
&#xD;
This archetype may be redundant in situations where ordering a medication via prescription uses a terminology to identify the medication item. In that case the brand or product name may identify the form and strength of the substance. (en)</use>
      <misuse>*Not to be used for pharmacy stock-control or within medication catalogues.&#xD;
&#xD;
Not to be used to record the intended or administered dose of a medication. Use either the INSTRUCTION.medication_order or the CLUSTER.dosage archetypes for this purpose.&#xD;
&#xD;
Not to be used by itself to populate a medication list. Use a relevant medication-related ENTRY archetype such as INSTRUCTION.medication_order or ACTION.medication for this purpose. (en)</misuse>
      <copyright />
    </details>
    <details>
      <language>
        <terminology_id>
          <value>ISO_639-1</value>
        </terminology_id>
        <code_string>nb</code_string>
      </language>
      <purpose>For å registrere detaljer om et legemiddel eller en komponent av et legemiddel, inkludert detaljer om spesifikke bestanddeler.</purpose>
      <keywords>legemiddel</keywords>
      <keywords>tilbereding</keywords>
      <keywords>ordinering</keywords>
      <keywords>forskrive</keywords>
      <keywords>terapi</keywords>
      <keywords>substans</keywords>
      <keywords>medikament</keywords>
      <keywords>terapeutisk</keywords>
      <keywords>medikamenter solgt over disk</keywords>
      <keywords>vare</keywords>
      <keywords>magistrell</keywords>
      <keywords>ex tempore</keywords>
      <keywords>blanding</keywords>
      <keywords>virkestoff</keywords>
      <keywords>hjelpestoff</keywords>
      <keywords>utblanding</keywords>
      <keywords>foreskrive</keywords>
      <keywords>forordne</keywords>
      <use>Brukes for å registrere detaljer om et legemiddel eller en komponent av et legemiddel, inkludert detaljer om spesifikke bestanddeler.&#xD;
&#xD;
Denne arketypen er laget for å brukes til å registrere detaljer om et legemiddel eller en komponent av et legemiddel, der formen og detaljer om bestanddelene må oppgis i mer detalj. Eksempler kan være infusjoner og magistrellforskrevne blandinger, eller der det ikke finnes en tilgjengelig legemiddelterminologi. I sammenhenger der et legemiddel skal administreres eller ekspederes skal denne arketypen nøstes i SLOTet Legemiddeldetaljer i arketypen INSTRUCTION.medication_order. I sammenhenger der det skal registreres hvilket legemiddel som faktisk ble administrert eller ekspedert skal denne arketypen nøstes i SLOTet Legemiddeldetaljer i arketypen ACTION.medication.&#xD;
&#xD;
Denne arketypen kan være overflødig i situasjoner der en legemiddelordinering via resept bruker terminologi for å spesifisere legemiddelet. I slike tilfeller vil ofte form og styrke være angitt som en del av terminologibegrepet.</use>
      <misuse>Skal ikke brukes innen varelageroversikt for apotek, eller innen legemiddelkataloger.&#xD;
&#xD;
Skal ikke brukes for å registrere den tilsiktede eller administrerte dosen av et legemiddel. Bruk enten INSTRUCTION.medication_order eller CLUSTER.dosage til dette formålet.&#xD;
&#xD;
Skal ikke brukes alene for å populere en legemiddelliste. Bruk en relevant legemiddel-relatert ENTRY-arketype som INSTRUCTION.medication_order eller ACTION.medication for dette formålet.</misuse>
      <copyright />
    </details>
    <details>
      <language>
        <terminology_id>
          <value>ISO_639-1</value>
        </terminology_id>
        <code_string>en</code_string>
      </language>
      <purpose>To record details about a medication or component of a medication, including strength, form and details of any specific constituents.</purpose>
      <keywords>medication</keywords>
      <keywords>order</keywords>
      <keywords>prescribe</keywords>
      <keywords>therapy</keywords>
      <keywords>substance</keywords>
      <keywords>drug</keywords>
      <keywords>therapeutic</keywords>
      <keywords>therapeutic good</keywords>
      <keywords>ad-hoc</keywords>
      <keywords>adhoc</keywords>
      <keywords>ad hoc</keywords>
      <keywords>extemporaneous</keywords>
      <keywords>formulation</keywords>
      <keywords>medicine</keywords>
      <use>Use to record details about a medication or component of a medication, including strength, form and details of any specific constituents.&#xD;
&#xD;
This archetype is intended to be used to record details of a medication or component of a medication where the form and detailed ingredients of the medication need to be specified in more detail, for example, infusions and ad hoc mixtures, or where there is no medication terminology available. In the context of an order for administration or dispensing of a medication, nest this archetype within the 'Medication details' SLOT within the INSTRUCTION.medication_order archetype. In the context of recording the actual administration or dispensing or a medication, nest this archetype within the 'Medication details' SLOT within the ACTION.medication archetype.&#xD;
&#xD;
This archetype may be redundant in situations where ordering a medication via prescription uses a terminology to identify the medication item. In that case the brand or product name may identify the form and strength of the substance.</use>
      <misuse>Not to be used for pharmacy stock-control or within medication catalogues.&#xD;
&#xD;
Not to be used to record the intended or administered dose of a medication. Use either the INSTRUCTION.medication_order or the CLUSTER.dosage archetypes for this purpose.&#xD;
&#xD;
Not to be used by itself to populate a medication list. Use a relevant medication-related ENTRY archetype such as INSTRUCTION.medication_order or ACTION.medication for this purpose.</misuse>
      <copyright>© openEHR Foundation</copyright>
    </details>
    <details>
      <language>
        <terminology_id>
          <value>ISO_639-1</value>
        </terminology_id>
        <code_string>fr</code_string>
      </language>
      <purpose>Pour enregistrer les informations relatives à un médicament ou à l'un de ses composants, notamment le dosage, la forme galénique et les détails concernant tout constituant spécifique.</purpose>
      <keywords>médicament</keywords>
      <keywords>ordonner</keywords>
      <keywords>prescrire</keywords>
      <keywords>thérapie</keywords>
      <keywords>substance</keywords>
      <keywords>médicament</keywords>
      <keywords>thérapeutique</keywords>
      <keywords>produit thérapeutique</keywords>
      <keywords>ad hoc</keywords>
      <keywords>adhoc</keywords>
      <keywords>ad hoc</keywords>
      <keywords>préparé sur place</keywords>
      <keywords>formulation</keywords>
      <keywords>médicament</keywords>
      <use>À utiliser pour enregistrer les détails relatifs à un médicament ou à un composant d’un médicament, notamment le dosage, la forme galénique et les détails concernant tout constituant spécifique.&#xD;
&#xD;
Cet archétype est destiné à être utilisé pour enregistrer les détails d’un médicament ou d’un composant d’un médicament quand la forme galénique et la composition détaillée du médicament doivent être précisées de manière plus détaillée, par exemple dans le cas de perfusions et de préparations ad hoc, ou lorsqu’il n’existe pas de terminologie de médicaments. Dans le cadre d’une demande d’administration ou de distribution d’un médicament, imbriquez cet archétype dans le SLOT « Détails du médicament » de l’archétype INSTRUCTION.medication_order. Dans le cadre de l’enregistrement de l’administration ou de la distribution effective d’un médicament, imbriquez cet archétype dans le SLOT « Détails du médicament » de l’archétype ACTION.medication.&#xD;
&#xD;
Cet archétype peut s’avérer redondant dans les situations où la prescription d’un médicament utilise une terminologie permettant d’identifier le produit. Dans ce cas, la marque ou le nom du produit peut permettre d’identifier la forme et le dosage de la substance.</use>
      <misuse>À ne pas utiliser pour enregistrer la dose prévue ou administrée d’un médicament. Utilisez à cette fin l’archétype INSTRUCTION.medication_order ou CLUSTER.dosage.&#xD;
&#xD;
À ne pas utiliser pour enregister une liste de médicaments. Utilisez à cette fin un archétype ENTRY pertinent lié aux médicaments, tel que INSTRUCTION.medication_order ou ACTION.medication.</misuse>
      <copyright />
    </details>
    <details>
      <language>
        <terminology_id>
          <value>ISO_639-1</value>
        </terminology_id>
        <code_string>nl</code_string>
      </language>
      <purpose>Het vastleggen van gegevens over een medicament of een onderdeel van een medicament, inclusief sterkte, vorm en details van een specifiek bestandsdeel.</purpose>
      <keywords>medicatie</keywords>
      <keywords>recept</keywords>
      <keywords>voorschrijven</keywords>
      <keywords>behandeling</keywords>
      <keywords>substantie</keywords>
      <keywords>medicament</keywords>
      <keywords>therapeuticum</keywords>
      <keywords>therapeutische substantie</keywords>
      <keywords>ad-hoc</keywords>
      <keywords>adhoc</keywords>
      <keywords>ad hoc</keywords>
      <keywords>medicijn</keywords>
      <use>*Use to record details about a medication or component of a medication, including strength, form and details of any specific constituents.&#xD;
&#xD;
This archetype is intended to be used to record details of a medication or component of a medication where the form and detailed ingredients of the medication need to be specified in more detail, for example, infusions and ad hoc mixtures, or where there is no medication terminology available. In the context of an order for administration or dispensing of a medication, nest this archetype within the Preparation details SLOT within the INSTRUCTION.medication_order archetype. In the context of recording the actual administration or dispensing or a medication, nest this archetype within the 'Medication details' SLOT within the ACTION.medication archetype.&#xD;
&#xD;
This archetype may be redundant in situations where ordering a medication via prescription uses a terminology to identify the medication item. In that case the brand or product name may identify the form and strength of the substance. (en)</use>
      <misuse>*Not to be used for pharmacy stock-control or within medication catalogues.&#xD;
&#xD;
Not to be used to record the intended or administered dose of a medication. Use either the INSTRUCTION.medication_order or the CLUSTER.dosage archetypes for this purpose.&#xD;
&#xD;
Not to be used by itself to populate a medication list. Use a relevant medication-related ENTRY archetype such as INSTRUCTION.medication_order or ACTION.medication for this purpose. (en)</misuse>
      <copyright />
    </details>
    <details>
      <language>
        <terminology_id>
          <value>ISO_639-1</value>
        </terminology_id>
        <code_string>ca</code_string>
      </language>
      <purpose>Registrar detalls sobre un medicament o un component d'un medicament, inclosa la concentració, la forma i els detalls de qualsevol component específic.</purpose>
      <keywords>medicació</keywords>
      <keywords>ordre</keywords>
      <keywords>prescriure</keywords>
      <keywords>teràpia</keywords>
      <keywords>substància</keywords>
      <keywords>medicament</keywords>
      <keywords>terapèutic</keywords>
      <keywords>bé terapèutic</keywords>
      <keywords>ad-hoc</keywords>
      <keywords>adhoc</keywords>
      <keywords>ad hoc</keywords>
      <keywords>extemporani</keywords>
      <keywords>formulació</keywords>
      <keywords>medicina</keywords>
      <use>S'utilitza per registrar detalls sobre un medicament o un component d'un medicament, inclosa la concentració, la forma i els detalls de qualsevol component específic.&#xD;
&#xD;
Aquest arquetip està pensat per registrar detalls d'un medicament o component d'un medicament quan calgui especificar amb més detall la forma i els components detallats del medicament, per exemple infusions i barreges ad hoc, o quan no es disposi de terminologia de medicaments. En el context d'una ordre d'administració o dispensació d'un medicament, anideu aquest arquetip al SLOT "Detalls del medicament" dins de l'arquetip INSTRUCTION.medication_order. En el context del registre de l'administració o dispensació real d'un medicament, anideu aquest arquetip al SLOT "Detalls del medicament" dins de l'arquetip ACTION.medication.&#xD;
&#xD;
Aquest arquetip pot ser redundant en situacions en què la sol·licitud dun medicament mitjançant recepta faci ús duna terminologia per identificar larticle. En aquest cas, la marca o el nom del producte poden identificar la forma i la concentració de la substància.</use>
      <misuse>No s'ha de fer servir per portar el control de l'estoc de farmàcia ni dels catàlegs de medicaments.&#xD;
&#xD;
No s'ha de fer servir per registrar la dosi prevista o administrada d'un medicament. Per fer-ho, utilitzeu els arquetips INSTRUCTION.medication_order o CLUSTER.dosage.&#xD;
&#xD;
No s'ha de fer servir per si mateix per emplenar una llista de medicació. Per fer-ho, utilitzeu un arquetip de tipus ENTRY relacionat amb la medicació, com INSTRUCTION.medication_order o ACTION.medication.</misuse>
      <copyright />
    </details>
    <details>
      <language>
        <terminology_id>
          <value>ISO_639-1</value>
        </terminology_id>
        <code_string>es</code_string>
      </language>
      <purpose>Registrar datos sobre un medicamento o componente de un medicamento, incluida la dosis, la forma y los detalles de cualquier componente específico.</purpose>
      <keywords>medicación</keywords>
      <keywords>prescripción</keywords>
      <keywords>prescribir</keywords>
      <keywords>terapia</keywords>
      <keywords>substancia</keywords>
      <keywords>droga</keywords>
      <keywords>fármaco</keywords>
      <keywords>terapéutico</keywords>
      <keywords>producto terapéutico</keywords>
      <keywords>ad-hoc</keywords>
      <keywords>ad hoc</keywords>
      <keywords>extemporáneo</keywords>
      <keywords>formulación</keywords>
      <keywords>medicina</keywords>
      <use>Usar para registrar detalles sobre un medicamento o componente de un medicamento, incluyendo la dosis, la forma y los detalles de cualquier componente específico.&#xD;
&#xD;
Este arquetipo está diseñado para registrar datos de un medicamento o de un componente del mismo cuando se necesite especificar con mayor detalle la forma y los componentes del medicamento. Por ejemplo, en el caso de infusiones, mezclas preparadas ad hoc, o cuando no se disponga de una terminología estandarizada de medicamentos.&#xD;
&#xD;
En el contexto de una prescripción, administración o dispensación de un medicamento, este arquetipo debe ubicarse dentro del SLOT «Datos de la medicación» del arquetipo INSTRUCTION.medication_order. En el caso del registro de la administración o dispensación real del medicamento, se debe ubicar dentro del SLOT «Datos de la medicación» del arquetipo ACTION.medication.&#xD;
&#xD;
Este arquetipo puede resultar redundante en situaciones donde se solicite un medicamento mediante una prescripción que utiliza una terminología codificada para identificar el medicamento. En estos casos, la marca o el nombre del producto ya pueden implicar la forma farmacéutica y la concentración de la sustancia.</use>
      <misuse>No utilizar para el control del inventario de farmacia ni dentro de los catálogos de medicamentos.&#xD;
&#xD;
No utilizar para registrar la dosis prevista o administrada de un medicamento. Utilizar los arquetipos INSTRUCTION.medication_order o CLUSTER.dosage para esta finalidad.&#xD;
&#xD;
No utilizar por sí mismo para rellenar una lista de medicación. Utilizar un arquetipo relevante de tipo ENTRY relacionado con la medicación, como INSTRUCTION.medication_order o ACTION.medication para esta finalidad.</misuse>
      <copyright />
    </details>
  </description>
  <translations>
    <language>
      <terminology_id>
        <value>ISO_639-1</value>
      </terminology_id>
      <code_string>de</code_string>
    </language>
    <author id="name">Ramona Wellmann, Natalia Strauch</author>
    <author id="organisation">Medizinische Hochschule Hannover</author>
    <author id="email">wellmann.ramona@mh-hannover.de, Strauch.Natalia@mh-hannover.de</author>
  </translations>
  <translations>
    <language>
      <terminology_id>
        <value>ISO_639-1</value>
      </terminology_id>
      <code_string>sv</code_string>
    </language>
    <author id="name">Sofia Janstad, Jörgen Kuylenstierna, Åsa Skagerhult, Linda Aulin Lundeqvist, Samira Nikman, Manna Vosta, Rikard Lövström</author>
    <author id="organisation">SLL, eWeave AB, Västra Götalandsregionen, Karolinska universitetssjukhuset, Karolinska University Hospital</author>
    <author id="email">sofia.lang-janstad@sll.se, jorgen.kuylenstierna@solvikshalsan.se, asa.skagerhult@vgregion.se, linda.aulin-lundeqvist@regionstockholm.se, samira.nikman@regionstockholm.se, rikard.lovstrom@regionstockholm.se, manna.vosta@regionstockholm.se</author>
  </translations>
  <translations>
    <language>
      <terminology_id>
        <value>ISO_639-1</value>
      </terminology_id>
      <code_string>nb</code_string>
    </language>
    <author id="name">Silje Ljosland Bakke</author>
    <author id="organisation">Nasjonal IKT HF, Helse Vest IKT AS</author>
    <author id="email">silje.ljosland.bakke@helse-vest-ikt.no</author>
  </translations>
  <translations>
    <language>
      <terminology_id>
        <value>ISO_639-1</value>
      </terminology_id>
      <code_string>pt</code_string>
    </language>
    <author id="name">Beatriz de Faria Leao</author>
    <author id="organisation">Bleao Informática em Saúde</author>
    <author id="email">bfleao@terra.com.br</author>
    <accreditation>MD, PhD</accreditation>
  </translations>
  <translations>
    <language>
      <terminology_id>
        <value>ISO_639-1</value>
      </terminology_id>
      <code_string>fr</code_string>
    </language>
    <author id="name">Jonas Bucher</author>
    <author id="organisation">Cistec AG</author>
    <author id="email">jonas.bucher@cistec.com</author>
  </translations>
  <translations>
    <language>
      <terminology_id>
        <value>ISO_639-1</value>
      </terminology_id>
      <code_string>nl</code_string>
    </language>
    <author id="name">Joost Holslag</author>
    <author id="organisation">Nedap</author>
    <author id="email">joost.holslag@nedap.com</author>
    <accreditation>MD</accreditation>
  </translations>
  <translations>
    <language>
      <terminology_id>
        <value>ISO_639-1</value>
      </terminology_id>
      <code_string>ca</code_string>
    </language>
    <author id="name">Julio de Sosa</author>
    <author id="organisation">Servei Català de la Salut</author>
    <author id="email">juliodesosa@catsalut.cat</author>
  </translations>
  <translations>
    <language>
      <terminology_id>
        <value>ISO_639-1</value>
      </terminology_id>
      <code_string>es</code_string>
    </language>
    <author id="name">Laura Moral Lopez</author>
    <author id="organisation">Sistema de Salut de Catalunya</author>
    <author id="email">lauramoral@catsalut.cat</author>
  </translations>
  <uid>
    <value>b222a76b-6f91-4e78-b669-0d776747a789</value>
  </uid>
  <archetype_id>
    <value>openEHR-EHR-CLUSTER.medication.v2</value>
  </archetype_id>
  <adl_version>1.4</adl_version>
  <concept>at0000</concept>
  <definition>
    <rm_type_name>CLUSTER</rm_type_name>
    <occurrences>
      <lower_included>true</lower_included>
      <upper_included>true</upper_included>
      <lower_unbounded>false</lower_unbounded>
      <upper_unbounded>false</upper_unbounded>
      <lower>0</lower>
      <upper>1</upper>
    </occurrences>
    <node_id>at0000</node_id>
    <attributes xsi:type="C_MULTIPLE_ATTRIBUTE">
      <rm_attribute_name>items</rm_attribute_name>
      <existence>
        <lower_included>true</lower_included>
        <upper_included>true</upper_included>
        <lower_unbounded>false</lower_unbounded>
        <upper_unbounded>false</upper_unbounded>
        <lower>1</lower>
        <upper>1</upper>
      </existence>
      <children xsi:type="C_COMPLEX_OBJECT">
        <rm_type_name>ELEMENT</rm_type_name>
        <occurrences>
          <lower_included>true</lower_included>
          <upper_included>true</upper_included>
          <lower_unbounded>false</lower_unbounded>
          <upper_unbounded>false</upper_unbounded>
          <lower>0</lower>
          <upper>1</upper>
        </occurrences>
        <node_id>at0132</node_id>
        <attributes xsi:type="C_SINGLE_ATTRIBUTE">
          <rm_attribute_name>value</rm_attribute_name>
          <existence>
            <lower_included>true</lower_included>
            <upper_included>true</upper_included>
            <lower_unbounded>false</lower_unbounded>
            <upper_unbounded>false</upper_unbounded>
            <lower>0</lower>
            <upper>1</upper>
          </existence>
          <children xsi:type="C_COMPLEX_OBJECT">
            <rm_type_name>DV_TEXT</rm_type_name>
            <occurrences>
              <lower_included>true</lower_included>
              <upper_included>true</upper_included>
              <lower_unbounded>false</lower_unbounded>
              <upper_unbounded>false</upper_unbounded>
              <lower>1</lower>
              <upper>1</upper>
            </occurrences>
            <node_id />
          </children>
        </attributes>
      </children>
      <children xsi:type="C_COMPLEX_OBJECT">
        <rm_type_name>ELEMENT</rm_type_name>
        <occurrences>
          <lower_included>true</lower_included>
          <lower_unbounded>false</lower_unbounded>
          <upper_unbounded>true</upper_unbounded>
          <lower>0</lower>
        </occurrences>
        <node_id>at0071</node_id>
        <attributes xsi:type="C_SINGLE_ATTRIBUTE">
          <rm_attribute_name>value</rm_attribute_name>
          <existence>
            <lower_included>true</lower_included>
            <upper_included>true</upper_included>
            <lower_unbounded>false</lower_unbounded>
            <upper_unbounded>false</upper_unbounded>
            <lower>0</lower>
            <upper>1</upper>
          </existence>
          <children xsi:type="C_COMPLEX_OBJECT">
            <rm_type_name>DV_TEXT</rm_type_name>
            <occurrences>
              <lower_included>true</lower_included>
              <upper_included>true</upper_included>
              <lower_unbounded>false</lower_unbounded>
              <upper_unbounded>false</upper_unbounded>
              <lower>1</lower>
              <upper>1</upper>
            </occurrences>
            <node_id />
          </children>
        </attributes>
      </children>
      <children xsi:type="C_COMPLEX_OBJECT">
        <rm_type_name>ELEMENT</rm_type_name>
        <occurrences>
          <lower_included>true</lower_included>
          <upper_included>true</upper_included>
          <lower_unbounded>false</lower_unbounded>
          <upper_unbounded>false</upper_unbounded>
          <lower>0</lower>
          <upper>1</upper>
        </occurrences>
        <node_id>at0142</node_id>
        <attributes xsi:type="C_SINGLE_ATTRIBUTE">
          <rm_attribute_name>value</rm_attribute_name>
          <existence>
            <lower_included>true</lower_included>
            <upper_included>true</upper_included>
            <lower_unbounded>false</lower_unbounded>
            <upper_unbounded>false</upper_unbounded>
            <lower>0</lower>
            <upper>1</upper>
          </existence>
          <children xsi:type="C_COMPLEX_OBJECT">
            <rm_type_name>DV_CODED_TEXT</rm_type_name>
            <occurrences>
              <lower_included>true</lower_included>
              <upper_included>true</upper_included>
              <lower_unbounded>false</lower_unbounded>
              <upper_unbounded>false</upper_unbounded>
              <lower>1</lower>
              <upper>1</upper>
            </occurrences>
            <node_id />
            <attributes xsi:type="C_SINGLE_ATTRIBUTE">
              <rm_attribute_name>defining_code</rm_attribute_name>
              <existence>
                <lower_included>true</lower_included>
                <upper_included>true</upper_included>
                <lower_unbounded>false</lower_unbounded>
                <upper_unbounded>false</upper_unbounded>
                <lower>1</lower>
                <upper>1</upper>
              </existence>
              <children xsi:type="C_CODE_PHRASE">
                <rm_type_name>CODE_PHRASE</rm_type_name>
                <occurrences>
                  <lower_included>true</lower_included>
                  <upper_included>true</upper_included>
                  <lower_unbounded>false</lower_unbounded>
                  <upper_unbounded>false</upper_unbounded>
                  <lower>1</lower>
                  <upper>1</upper>
                </occurrences>
                <node_id />
                <terminology_id>
                  <value>local</value>
                </terminology_id>
                <code_list>at0143</code_list>
                <code_list>at0146</code_list>
                <code_list>at0144</code_list>
                <code_list>at0145</code_list>
                <code_list>at0001</code_list>
              </children>
            </attributes>
          </children>
          <children xsi:type="C_COMPLEX_OBJECT">
            <rm_type_name>DV_TEXT</rm_type_name>
            <occurrences>
              <lower_included>true</lower_included>
              <upper_included>true</upper_included>
              <lower_unbounded>false</lower_unbounded>
              <upper_unbounded>false</upper_unbounded>
              <lower>1</lower>
              <upper>1</upper>
            </occurrences>
            <node_id />
          </children>
        </attributes>
      </children>
      <children xsi:type="C_COMPLEX_OBJECT">
        <rm_type_name>CLUSTER</rm_type_name>
        <occurrences>
          <lower_included>true</lower_included>
          <upper_included>true</upper_included>
          <lower_unbounded>false</lower_unbounded>
          <upper_unbounded>false</upper_unbounded>
          <lower>0</lower>
          <upper>1</upper>
        </occurrences>
        <node_id>at0152</node_id>
        <attributes xsi:type="C_MULTIPLE_ATTRIBUTE">
          <rm_attribute_name>items</rm_attribute_name>
          <existence>
            <lower_included>true</lower_included>
            <upper_included>true</upper_included>
            <lower_unbounded>false</lower_unbounded>
            <upper_unbounded>false</upper_unbounded>
            <lower>1</lower>
            <upper>1</upper>
          </existence>
          <children xsi:type="C_COMPLEX_OBJECT">
            <rm_type_name>ELEMENT</rm_type_name>
            <occurrences>
              <lower_included>true</lower_included>
              <upper_included>true</upper_included>
              <lower_unbounded>false</lower_unbounded>
              <upper_unbounded>false</upper_unbounded>
              <lower>1</lower>
              <upper>1</upper>
            </occurrences>
            <node_id>at0153</node_id>
            <attributes xsi:type="C_SINGLE_ATTRIBUTE">
              <rm_attribute_name>value</rm_attribute_name>
              <existence>
                <lower_included>true</lower_included>
                <upper_included>true</upper_included>
                <lower_unbounded>false</lower_unbounded>
                <upper_unbounded>false</upper_unbounded>
                <lower>0</lower>
                <upper>1</upper>
              </existence>
              <children xsi:type="C_COMPLEX_OBJECT">
                <rm_type_name>DV_QUANTITY</rm_type_name>
                <occurrences>
                  <lower_included>true</lower_included>
                  <upper_included>true</upper_included>
                  <lower_unbounded>false</lower_unbounded>
                  <upper_unbounded>false</upper_unbounded>
                  <lower>1</lower>
                  <upper>1</upper>
                </occurrences>
                <node_id />
              </children>
            </attributes>
          </children>
          <children xsi:type="C_COMPLEX_OBJECT">
            <rm_type_name>ELEMENT</rm_type_name>
            <occurrences>
              <lower_included>true</lower_included>
              <upper_included>true</upper_included>
              <lower_unbounded>false</lower_unbounded>
              <upper_unbounded>false</upper_unbounded>
              <lower>1</lower>
              <upper>1</upper>
            </occurrences>
            <node_id>at0157</node_id>
            <attributes xsi:type="C_SINGLE_ATTRIBUTE">
              <rm_attribute_name>value</rm_attribute_name>
              <existence>
                <lower_included>true</lower_included>
                <upper_included>true</upper_included>
                <lower_unbounded>false</lower_unbounded>
                <upper_unbounded>false</upper_unbounded>
                <lower>0</lower>
                <upper>1</upper>
              </existence>
              <children xsi:type="C_COMPLEX_OBJECT">
                <rm_type_name>DV_QUANTITY</rm_type_name>
                <occurrences>
                  <lower_included>true</lower_included>
                  <upper_included>true</upper_included>
                  <lower_unbounded>false</lower_unbounded>
                  <upper_unbounded>false</upper_unbounded>
                  <lower>1</lower>
                  <upper>1</upper>
                </occurrences>
                <node_id />
              </children>
            </attributes>
          </children>
          <cardinality>
            <is_ordered>false</is_ordered>
            <is_unique>false</is_unique>
            <interval>
              <lower_included>true</lower_included>
              <lower_unbounded>false</lower_unbounded>
              <upper_unbounded>true</upper_unbounded>
              <lower>1</lower>
            </interval>
          </cardinality>
        </attributes>
      </children>
      <children xsi:type="C_COMPLEX_OBJECT">
        <rm_type_name>ELEMENT</rm_type_name>
        <occurrences>
          <lower_included>true</lower_included>
          <upper_included>true</upper_included>
          <lower_unbounded>false</lower_unbounded>
          <upper_unbounded>false</upper_unbounded>
          <lower>0</lower>
          <upper>1</upper>
        </occurrences>
        <node_id>at0115</node_id>
        <attributes xsi:type="C_SINGLE_ATTRIBUTE">
          <rm_attribute_name>value</rm_attribute_name>
          <existence>
            <lower_included>true</lower_included>
            <upper_included>true</upper_included>
            <lower_unbounded>false</lower_unbounded>
            <upper_unbounded>false</upper_unbounded>
            <lower>0</lower>
            <upper>1</upper>
          </existence>
          <children xsi:type="C_COMPLEX_OBJECT">
            <rm_type_name>DV_QUANTITY</rm_type_name>
            <occurrences>
              <lower_included>true</lower_included>
              <upper_included>true</upper_included>
              <lower_unbounded>false</lower_unbounded>
              <upper_unbounded>false</upper_unbounded>
              <lower>1</lower>
              <upper>1</upper>
            </occurrences>
            <node_id />
          </children>
        </attributes>
      </children>
      <children xsi:type="C_COMPLEX_OBJECT">
        <rm_type_name>ELEMENT</rm_type_name>
        <occurrences>
          <lower_included>true</lower_included>
          <upper_included>true</upper_included>
          <lower_unbounded>false</lower_unbounded>
          <upper_unbounded>false</upper_unbounded>
          <lower>0</lower>
          <upper>1</upper>
        </occurrences>
        <node_id>at0151</node_id>
        <attributes xsi:type="C_SINGLE_ATTRIBUTE">
          <rm_attribute_name>value</rm_attribute_name>
          <existence>
            <lower_included>true</lower_included>
            <upper_included>true</upper_included>
            <lower_unbounded>false</lower_unbounded>
            <upper_unbounded>false</upper_unbounded>
            <lower>0</lower>
            <upper>1</upper>
          </existence>
          <children xsi:type="C_COMPLEX_OBJECT">
            <rm_type_name>DV_TEXT</rm_type_name>
            <occurrences>
              <lower_included>true</lower_included>
              <upper_included>true</upper_included>
              <lower_unbounded>false</lower_unbounded>
              <upper_unbounded>false</upper_unbounded>
              <lower>1</lower>
              <upper>1</upper>
            </occurrences>
            <node_id />
          </children>
        </attributes>
      </children>
      <children xsi:type="C_COMPLEX_OBJECT">
        <rm_type_name>ELEMENT</rm_type_name>
        <occurrences>
          <lower_included>true</lower_included>
          <lower_unbounded>false</lower_unbounded>
          <upper_unbounded>true</upper_unbounded>
          <lower>0</lower>
        </occurrences>
        <node_id>at0150</node_id>
        <attributes xsi:type="C_SINGLE_ATTRIBUTE">
          <rm_attribute_name>value</rm_attribute_name>
          <existence>
            <lower_included>true</lower_included>
            <upper_included>true</upper_included>
            <lower_unbounded>false</lower_unbounded>
            <upper_unbounded>false</upper_unbounded>
            <lower>0</lower>
            <upper>1</upper>
          </existence>
          <children xsi:type="C_COMPLEX_OBJECT">
            <rm_type_name>DV_TEXT</rm_type_name>
            <occurrences>
              <lower_included>true</lower_included>
              <upper_included>true</upper_included>
              <lower_unbounded>false</lower_unbounded>
              <upper_unbounded>false</upper_unbounded>
              <lower>1</lower>
              <upper>1</upper>
            </occurrences>
            <node_id />
          </children>
          <children xsi:type="C_COMPLEX_OBJECT">
            <rm_type_name>DV_IDENTIFIER</rm_type_name>
            <occurrences>
              <lower_included>true</lower_included>
              <upper_included>true</upper_included>
              <lower_unbounded>false</lower_unbounded>
              <upper_unbounded>false</upper_unbounded>
              <lower>1</lower>
              <upper>1</upper>
            </occurrences>
            <node_id />
          </children>
        </attributes>
      </children>
      <children xsi:type="C_COMPLEX_OBJECT">
        <rm_type_name>ELEMENT</rm_type_name>
        <occurrences>
          <lower_included>true</lower_included>
          <upper_included>true</upper_included>
          <lower_unbounded>false</lower_unbounded>
          <upper_unbounded>false</upper_unbounded>
          <lower>0</lower>
          <upper>1</upper>
        </occurrences>
        <node_id>at0003</node_id>
        <attributes xsi:type="C_SINGLE_ATTRIBUTE">
          <rm_attribute_name>value</rm_attribute_name>
          <existence>
            <lower_included>true</lower_included>
            <upper_included>true</upper_included>
            <lower_unbounded>false</lower_unbounded>
            <upper_unbounded>false</upper_unbounded>
            <lower>0</lower>
            <upper>1</upper>
          </existence>
          <children xsi:type="C_COMPLEX_OBJECT">
            <rm_type_name>DV_DATE_TIME</rm_type_name>
            <occurrences>
              <lower_included>true</lower_included>
              <upper_included>true</upper_included>
              <lower_unbounded>false</lower_unbounded>
              <upper_unbounded>false</upper_unbounded>
              <lower>1</lower>
              <upper>1</upper>
            </occurrences>
            <node_id />
          </children>
        </attributes>
      </children>
      <children xsi:type="ARCHETYPE_SLOT">
        <rm_type_name>CLUSTER</rm_type_name>
        <occurrences>
          <lower_included>true</lower_included>
          <lower_unbounded>false</lower_unbounded>
          <upper_unbounded>true</upper_unbounded>
          <lower>0</lower>
        </occurrences>
        <node_id>at0138</node_id>
        <includes>
          <string_expression>archetype_id/value matches {/openEHR-EHR-CLUSTER\.medication(-[a-zA-Z0-9_]+)*\.v1|openEHR-EHR-CLUSTER\.medication(-[a-zA-Z0-9_]+)*\.v2/}</string_expression>
          <expression xsi:type="EXPR_BINARY_OPERATOR">
            <type>Boolean</type>
            <operator>2007</operator>
            <precedence_overridden>false</precedence_overridden>
            <left_operand xsi:type="EXPR_LEAF">
              <type>String</type>
              <item xsi:type="xsd:string">archetype_id/value</item>
              <reference_type>attribute</reference_type>
            </left_operand>
            <right_operand xsi:type="EXPR_LEAF">
              <type>C_STRING</type>
              <item xsi:type="C_STRING">
                <pattern>openEHR-EHR-CLUSTER\.medication(-[a-zA-Z0-9_]+)*\.v1|openEHR-EHR-CLUSTER\.medication(-[a-zA-Z0-9_]+)*\.v2</pattern>
              </item>
              <reference_type>constraint</reference_type>
            </right_operand>
          </expression>
        </includes>
      </children>
      <children xsi:type="C_COMPLEX_OBJECT">
        <rm_type_name>ELEMENT</rm_type_name>
        <occurrences>
          <lower_included>true</lower_included>
          <upper_included>true</upper_included>
          <lower_unbounded>false</lower_unbounded>
          <upper_unbounded>false</upper_unbounded>
          <lower>0</lower>
          <upper>1</upper>
        </occurrences>
        <node_id>at0139</node_id>
        <attributes xsi:type="C_SINGLE_ATTRIBUTE">
          <rm_attribute_name>value</rm_attribute_name>
          <existence>
            <lower_included>true</lower_included>
            <upper_included>true</upper_included>
            <lower_unbounded>false</lower_unbounded>
            <upper_unbounded>false</upper_unbounded>
            <lower>0</lower>
            <upper>1</upper>
          </existence>
          <children xsi:type="C_COMPLEX_OBJECT">
            <rm_type_name>DV_QUANTITY</rm_type_name>
            <occurrences>
              <lower_included>true</lower_included>
              <upper_included>true</upper_included>
              <lower_unbounded>false</lower_unbounded>
              <upper_unbounded>false</upper_unbounded>
              <lower>1</lower>
              <upper>1</upper>
            </occurrences>
            <node_id />
          </children>
        </attributes>
      </children>
      <children xsi:type="C_COMPLEX_OBJECT">
        <rm_type_name>ELEMENT</rm_type_name>
        <occurrences>
          <lower_included>true</lower_included>
          <upper_included>true</upper_included>
          <lower_unbounded>false</lower_unbounded>
          <upper_unbounded>false</upper_unbounded>
          <lower>0</lower>
          <upper>1</upper>
        </occurrences>
        <node_id>at0148</node_id>
        <attributes xsi:type="C_SINGLE_ATTRIBUTE">
          <rm_attribute_name>value</rm_attribute_name>
          <existence>
            <lower_included>true</lower_included>
            <upper_included>true</upper_included>
            <lower_unbounded>false</lower_unbounded>
            <upper_unbounded>false</upper_unbounded>
            <lower>0</lower>
            <upper>1</upper>
          </existence>
          <children xsi:type="C_COMPLEX_OBJECT">
            <rm_type_name>DV_QUANTITY</rm_type_name>
            <occurrences>
              <lower_included>true</lower_included>
              <upper_included>true</upper_included>
              <lower_unbounded>false</lower_unbounded>
              <upper_unbounded>false</upper_unbounded>
              <lower>1</lower>
              <upper>1</upper>
            </occurrences>
            <node_id />
          </children>
        </attributes>
      </children>
      <children xsi:type="C_COMPLEX_OBJECT">
        <rm_type_name>ELEMENT</rm_type_name>
        <occurrences>
          <lower_included>true</lower_included>
          <upper_included>true</upper_included>
          <lower_unbounded>false</lower_unbounded>
          <upper_unbounded>false</upper_unbounded>
          <lower>0</lower>
          <upper>1</upper>
        </occurrences>
        <node_id>at0127</node_id>
        <attributes xsi:type="C_SINGLE_ATTRIBUTE">
          <rm_attribute_name>value</rm_attribute_name>
          <existence>
            <lower_included>true</lower_included>
            <upper_included>true</upper_included>
            <lower_unbounded>false</lower_unbounded>
            <upper_unbounded>false</upper_unbounded>
            <lower>0</lower>
            <upper>1</upper>
          </existence>
          <children xsi:type="C_COMPLEX_OBJECT">
            <rm_type_name>DV_CODED_TEXT</rm_type_name>
            <occurrences>
              <lower_included>true</lower_included>
              <upper_included>true</upper_included>
              <lower_unbounded>false</lower_unbounded>
              <upper_unbounded>false</upper_unbounded>
              <lower>1</lower>
              <upper>1</upper>
            </occurrences>
            <node_id />
            <attributes xsi:type="C_SINGLE_ATTRIBUTE">
              <rm_attribute_name>defining_code</rm_attribute_name>
              <existence>
                <lower_included>true</lower_included>
                <upper_included>true</upper_included>
                <lower_unbounded>false</lower_unbounded>
                <upper_unbounded>false</upper_unbounded>
                <lower>1</lower>
                <upper>1</upper>
              </existence>
              <children xsi:type="C_CODE_PHRASE">
                <rm_type_name>CODE_PHRASE</rm_type_name>
                <occurrences>
                  <lower_included>true</lower_included>
                  <upper_included>true</upper_included>
                  <lower_unbounded>false</lower_unbounded>
                  <upper_unbounded>false</upper_unbounded>
                  <lower>1</lower>
                  <upper>1</upper>
                </occurrences>
                <node_id />
                <terminology_id>
                  <value>local</value>
                </terminology_id>
                <code_list>at0080</code_list>
                <code_list>at0083</code_list>
                <code_list>at0084</code_list>
              </children>
            </attributes>
          </children>
          <children xsi:type="C_COMPLEX_OBJECT">
            <rm_type_name>DV_TEXT</rm_type_name>
            <occurrences>
              <lower_included>true</lower_included>
              <upper_included>true</upper_included>
              <lower_unbounded>false</lower_unbounded>
              <upper_unbounded>false</upper_unbounded>
              <lower>1</lower>
              <upper>1</upper>
            </occurrences>
            <node_id />
          </children>
        </attributes>
      </children>
      <children xsi:type="C_COMPLEX_OBJECT">
        <rm_type_name>ELEMENT</rm_type_name>
        <occurrences>
          <lower_included>true</lower_included>
          <upper_included>true</upper_included>
          <lower_unbounded>false</lower_unbounded>
          <upper_unbounded>false</upper_unbounded>
          <lower>0</lower>
          <upper>1</upper>
        </occurrences>
        <node_id>at0133</node_id>
        <attributes xsi:type="C_SINGLE_ATTRIBUTE">
          <rm_attribute_name>value</rm_attribute_name>
          <existence>
            <lower_included>true</lower_included>
            <upper_included>true</upper_included>
            <lower_unbounded>false</lower_unbounded>
            <upper_unbounded>false</upper_unbounded>
            <lower>0</lower>
            <upper>1</upper>
          </existence>
          <children xsi:type="C_COMPLEX_OBJECT">
            <rm_type_name>DV_TEXT</rm_type_name>
            <occurrences>
              <lower_included>true</lower_included>
              <upper_included>true</upper_included>
              <lower_unbounded>false</lower_unbounded>
              <upper_unbounded>false</upper_unbounded>
              <lower>1</lower>
              <upper>1</upper>
            </occurrences>
            <node_id />
          </children>
        </attributes>
      </children>
      <children xsi:type="ARCHETYPE_SLOT">
        <rm_type_name>CLUSTER</rm_type_name>
        <occurrences>
          <lower_included>true</lower_included>
          <lower_unbounded>false</lower_unbounded>
          <upper_unbounded>true</upper_unbounded>
          <lower>0</lower>
        </occurrences>
        <node_id>at0141</node_id>
        <includes>
          <string_expression>archetype_id/value matches {/.*/}</string_expression>
          <expression xsi:type="EXPR_BINARY_OPERATOR">
            <type>Boolean</type>
            <operator>2007</operator>
            <precedence_overridden>false</precedence_overridden>
            <left_operand xsi:type="EXPR_LEAF">
              <type>String</type>
              <item xsi:type="xsd:string">archetype_id/value</item>
              <reference_type>attribute</reference_type>
            </left_operand>
            <right_operand xsi:type="EXPR_LEAF">
              <type>C_STRING</type>
              <item xsi:type="C_STRING">
                <pattern>.*</pattern>
              </item>
              <reference_type>constraint</reference_type>
            </right_operand>
          </expression>
        </includes>
      </children>
      <cardinality>
        <is_ordered>false</is_ordered>
        <is_unique>false</is_unique>
        <interval>
          <lower_included>true</lower_included>
          <lower_unbounded>false</lower_unbounded>
          <upper_unbounded>true</upper_unbounded>
          <lower>1</lower>
        </interval>
      </cardinality>
    </attributes>
  </definition>
  <ontology>
    <term_definitions language="en">
      <items code="at0000">
        <items id="text">Medication details</items>
        <items id="description">Details about a medication or component of a medication, including strength, form and details of any specific constituents.</items>
      </items>
      <items code="at0001">
        <items id="text">Combination product</items>
        <items id="description">The medication or medication component consists of a number of separate products which are pre-packaged by the manufacturer, for example Canesten Combi.</items>
      </items>
      <items code="at0003">
        <items id="text">Expiry</items>
        <items id="description">The expiry date and/or time of the medication or medication component, as given by the manufacturer or individual preparing the mixture.</items>
        <items id="comment">Any other form of expiry date, such as time from production or depending on storage environment, can be inserted using a specific CLUSTER archetype in the Substance Details slot or added as part of the Description.&#xD;
 For example: '2017-05-23'.</items>
      </items>
      <items code="at0071">
        <items id="text">Form</items>
        <items id="description">The formulation or presentation of the medication or medication component.</items>
        <items id="comment">For example: 'tablet', 'capsule', 'cream', 'infusion fluid' or 'inhalation powder'. Coding of the form with a terminology is preferred, where possible. Medicines catalogues may differentiate between administrable form 'solution for injection' and product form 'powder for solution for injection'. The recorded form will depend on the exact context of use but administrable form is likely to be used in most instances.</items>
      </items>
      <items code="at0080">
        <items id="text">Therapeutic</items>
        <items id="description">Constituent that alone or in combination with one or more other ingredients is considered to fulfil the intended activity of a medicinal product.</items>
      </items>
      <items code="at0083">
        <items id="text">Adjuvant</items>
        <items id="description">Constituent whose primary function is to modify the activity of an active constituent. An adjuvant constituent itself may or may not be therapeutically active.</items>
      </items>
      <items code="at0084">
        <items id="text">Excipient</items>
        <items id="description">Constituent that is inert in relation to the intended activity of the medicinal product.</items>
      </items>
      <items code="at0115">
        <items id="text">Strength (concentration)</items>
        <items id="description">The strength of the medication or medication component, as a concentration.</items>
        <items id="comment">This element is used for liquid or semisolid medications, or medications intended to be diluted in a liquid before administration. For example: '10 mg/ml', '20 mg/g', '5 %', '10,000 SQ-U/ml'. If the 'Strength (presentation)' cluster is used, this element becomes redundant.</items>
      </items>
      <items code="at0127">
        <items id="text">Role</items>
        <items id="description">The role of the medication or medication component within a mixture.</items>
      </items>
      <items code="at0132">
        <items id="text">Name</items>
        <items id="description">The name of the medication or medication component.</items>
        <items id="comment">For example: 'Zinacef 750 mg powder' or 'cefuroxim'. This item should be coded if possible, using for example, RxNorm, DM+D, Australian Medicines Terminology or FEST. Usage of this element will vary according to context of use. This element may be omitted where the name of the medication is recorded in the parent INSTRUCTION or ACTION archetype, and this archetype is only used to record that the form must be or was 'liquid'.</items>
      </items>
      <items code="at0133">
        <items id="text">Description</items>
        <items id="description">Narrative description of the medication or medication component where it is not possible to describe this fully using structured elements.</items>
      </items>
      <items code="at0138">
        <items id="text">Constituent</items>
        <items id="description">Details of an ingredient or product used to make up a mixed pack, preparation or infusion.</items>
        <items id="comment">This slot is intended to be used to add details about constituents of the medication or medication component, using nested instances of this archetype. This is not normally required other than where a mixture is being described.</items>
      </items>
      <items code="at0139">
        <items id="text">Amount</items>
        <items id="description">The amount of medication or medication component.</items>
        <items id="comment">For example: '1 ml', '1.5 mg', '1000 ml'.</items>
      </items>
      <items code="at0141">
        <items id="text">Structured details</items>
        <items id="description">Additional details about the medication or medication component.</items>
        <items id="comment">For example: detailed information about the drug class or intended routes, or additional expiry information.</items>
      </items>
      <items code="at0142">
        <items id="text">Category</items>
        <items id="description">The category of the medication or medication component, with regard to manufacturing or preparation, and the number of ingredients.</items>
        <items id="comment">For example: 'Paracetamol/codeine' is a Multi-ingredient product, while 'Morphine 60 mg + Haloperidol 2 mg + Midazolam 5 mg' is an Ad-hoc mixture, whose composition is fully specified within the order.</items>
      </items>
      <items code="at0143">
        <items id="text">Ad-hoc mixture</items>
        <items id="description">The medication or medication component is composed of a mixture of ingredients specified within the order. These are typically prepared by pharmacy or ward personnel to suit individual patients.</items>
      </items>
      <items code="at0144">
        <items id="text">Multi-ingredient product</items>
        <items id="description">The medication or medication component consists of a number of active ingredients which are pre-combined into a single form such as a tablet, cream or powder by the manufacturer, for example Paracetamol/codeine.</items>
      </items>
      <items code="at0145">
        <items id="text">Single-ingredient product</items>
        <items id="description">The medication or medication component is a manufactured product containing a single active ingredient.</items>
      </items>
      <items code="at0146">
        <items id="text">Ingredient</items>
        <items id="description">The medication or medication component is an individual ingredient of the medication. This term is used when the archetype is nested within a parent instance of itself, to describe the individual ingredients of a medication.</items>
      </items>
      <items code="at0148">
        <items id="text">Alternate amount</items>
        <items id="description">An equivalent representation of the amount of the medication or medication component.</items>
        <items id="comment">For example: for a medication with a strength of '5 mg/ml' and where the Amount is '1 ml', and the value recorded in this data element would be '5 mg'.</items>
      </items>
      <items code="at0150">
        <items id="text">Batch ID</items>
        <items id="description">The identifier assigned to the production batch by the manufacturer during production.</items>
      </items>
      <items code="at0151">
        <items id="text">Manufacturer</items>
        <items id="description">The manufacturer of the medication or medication component.</items>
        <items id="comment">For example: 'Abbott'.</items>
      </items>
      <items code="at0152">
        <items id="text">Strength (presentation)</items>
        <items id="description">The strength of the medication or medication component, expressed as a ratio.</items>
        <items id="comment">In some cases, as for liquid or semisolid medications, the denominator of the strength ratio is a physical quantity, for example 2 mg/5 ml. In some of these cases the denominator also reflects the actual volume of the component: 5 ml in the previous example. In this case the 'Strength (concentration)' would be 0.4 mg/ml. In other cases, where the strength involves a denominator which is not a physical quantity, for example 4 mg/tablet, the denominator is expressed as a unitary value '1' with a unit of 'tablet'. This arrangement was chosen to align with the approach adopted by the ISO IDMP standard for medication catalogues. If the 'Strength (concentration)' element is used, this cluster becomes redundant.</items>
      </items>
      <items code="at0153">
        <items id="text">Strength numerator</items>
        <items id="description">The numerator of the strength fraction.</items>
        <items id="comment">For example: For a presentation strength of '300 µg/0.3 ml', the strength numerator is '300 µg'. For a presentation strength of '100 mg/tablet', the strength numerator value is '100 mg'.</items>
      </items>
      <items code="at0157">
        <items id="text">Strength denominator</items>
        <items id="description">The denominator of the strength fraction.</items>
        <items id="comment">For example: For a presentation strength of '300 µg/0.3 ml', the strength denominator value is '0.3 ml'. For a presentation strength of '100 mg/tablet', the strength denominator value is '1 tablet'.</items>
      </items>
    </term_definitions>
    <term_definitions language="nb">
      <items code="at0000">
        <items id="text">Legemiddeldetaljer</items>
        <items id="description">Detaljer om et legemiddel eller en komponent av et legemiddel, inkludert detaljer om spesifikke bestanddeler.</items>
      </items>
      <items code="at0001">
        <items id="text">Kombinasjonspakning</items>
        <items id="description">Legemiddelet eller legemiddelkomponenten består av flere separate produkter som er forhåndspakket av produsenten, for eksempel Canesten vaginalkapsel + krem.</items>
      </items>
      <items code="at0003">
        <items id="text">Holdbarhetsdato</items>
        <items id="description">Tidspunktet for når legemiddelet ikke lenger skal benyttes, som angitt av produsenten eller den som tilbereder blandingen.</items>
        <items id="comment">For eksempel "2017-05-23". Andre former for utløpsdatoer som må dokumenteres, som for eksempel tid fra produksjonstidspunktet eller avhengighet av lagringsforhold, kan legges til som en spesifikk CLUSTER-arketype eller som en kommentar.</items>
      </items>
      <items code="at0071">
        <items id="text">Form</items>
        <items id="description">Formulering eller form av legemiddelet.</items>
        <items id="comment">For eksempel "tablett", "kapsel", "krem", infusjonsvæske". Koding av legemiddelformen med en terminologi foretrekkes der det er mulig. Legemiddelkataloger differensierer i noen tilfeller mellom administrerbar form, "injeksjonsvæske", og formen slik den er i pakken, "pulver til injeksjonsvæske". Formen som skal registreres kommer an på den eksakte brukssammenhengen, men i de fleste tilfeller vil administrerbar form være mest aktuelt.</items>
      </items>
      <items code="at0080">
        <items id="text">Terapeutisk</items>
        <items id="description">Bestanddel som alene eller i kombinasjon med en eller flere andre ingredienser oppfyller den tiltenkte aktiviteten av legemiddelet.</items>
      </items>
      <items code="at0083">
        <items id="text">Adjuvans</items>
        <items id="description">Bestanddel hvis hovedfunksjon er å modifisere aktiviteten av en aktiv bestanddel. En adjuvans kan i seg selv være enten aktiv eller inaktiv.</items>
      </items>
      <items code="at0084">
        <items id="text">Hjelpestoff</items>
        <items id="description">Bestanddel som er inaktiv i forhold til den tiltenkte aktiviteten av legemiddelet.</items>
      </items>
      <items code="at0115">
        <items id="text">Styrke (konsentrasjon)</items>
        <items id="description">Styrken av legemiddelet eller legemiddelkomponenten, angitt som konsentrasjon.</items>
        <items id="comment">Dette elementet brukes for flytende eller halvfaste legemidler, eller legemidler som skal blandes ut til å bli flytende før administrering. For eksempel "10 mg/ml", "20 mg/g", "5 %" eller "10 000 SQ-U/ml". Dersom clusteret "Styrke (presentasjon)" brukes, er dette clusteret overflødig.</items>
      </items>
      <items code="at0127">
        <items id="text">Rolle</items>
        <items id="description">Legemiddelet eller legemiddelkomponentens rolle i en blanding eller infusjon.</items>
      </items>
      <items code="at0132">
        <items id="text">Navn</items>
        <items id="description">Navnet på legemiddelet eller legemiddelkomponenten.</items>
        <items id="comment">For eksempel "Zinacef 750 mg pulver til infusjonsvæske" eller "cefuroxim". Dette elementet bør kodes om mulig, for eksempel med FEST. Bruk av dette elementet vil variere med brukssammenhengen. For eksempel vil elementet ikke brukes dersom legemiddelnavnet er registrert i den overordnede INSTRUCTION- eller ACTION-arketypen, og denne arketypen kun brukes for å registrere at legemiddelformen må være eller var "væske".</items>
      </items>
      <items code="at0133">
        <items id="text">Beskrivelse</items>
        <items id="description">Fritekstbeskrivelse av legemiddelet eller legemiddelkomponenten, der det ikke lar seg gjøre å beskrive dette fullstendig ved hjelp av strukturerte elementer.</items>
      </items>
      <items code="at0138">
        <items id="text">Bestanddel</items>
        <items id="description">Detaljer om en ingrediens eller produkt som brukes til å lage en blandet pakning, preparat eller infusjon.</items>
        <items id="comment">Dette SLOTet benyttes når arketypen nøstes inni en overordnet instans av den samme arketypen, for å beskrive de individuelle bestanddelene av et legemiddel. Dette er som regel ikke nødvendig, annet enn der en beskriver en blanding.</items>
      </items>
      <items code="at0139">
        <items id="text">Mengde</items>
        <items id="description">Mengden av legemiddelet eller legemiddelkomponenten.</items>
        <items id="comment">For eksempel "1 ml", "1,5 mg" eller "1000 ml".</items>
      </items>
      <items code="at0141">
        <items id="text">Strukturerte detaljer</items>
        <items id="description">Ytterligere detaljer om legemiddelet eller legemiddelkomponenten.</items>
        <items id="comment">For eksempel detaljert informasjon om legemiddelklassen, tiltenkte administrasjonsveier, eller ytterligere informasjon om holdbarhet.</items>
      </items>
      <items code="at0142">
        <items id="text">Kategori</items>
        <items id="description">Legemiddelet eller legemiddelkomponentens kategori med tanke på tilvirkning eller tilberedning, og antall ingredienser.</items>
        <items id="comment">For eksempel er Paralgin Forte et kombinasjonsprodukt, mens "Morfin 60 mg + Haloperidol 2 mg + Midazolam 5 mg" er en magistrellforskrevet blanding, som er fullt spesifisert i ordineringen.</items>
      </items>
      <items code="at0143">
        <items id="text">Magistrellforskrevet blanding</items>
        <items id="description">Legemiddelet eller legemiddelkomponenten er en sammensatt blanding av ingredienser som er spesifisert i en ordinering. Disse tillages typisk av apotek- eller sengepostpersonell for individuelle pasienter.</items>
      </items>
      <items code="at0144">
        <items id="text">Kombinasjonsprodukt</items>
        <items id="description">Komponenten består av flere aktive ingredienser som er satt sammen til én form som en tablett, krem eller pulver av produsenten. For eksempel Paralgin Forte.</items>
      </items>
      <items code="at0145">
        <items id="text">Produkt som inneholder én aktiv ingrediens</items>
        <items id="description">Legemiddelet eller legemiddelkomponenten er et fabrikkframstilt produkt som kun har én aktiv ingrediens.</items>
      </items>
      <items code="at0146">
        <items id="text">Bestanddel</items>
        <items id="description">Legemiddelkomponenten er en ingrediens i legemiddelet. Denne termen benyttes når arketypen nøstes inni en overordnet instans av den samme arketypen, for å beskrive de individuelle ingrediensene i et legemiddel.</items>
      </items>
      <items code="at0148">
        <items id="text">Alternativ mengde</items>
        <items id="description">En alternativ men tilsvarende angivelse av mengden legemiddel eller legemiddelkomponent.</items>
        <items id="comment">For eksempel dersom et legemiddel har styrke 5 mg/ml og mengden er "1 ml", vil verdien som registreres i dette dataelementet være "5 mg".</items>
      </items>
      <items code="at0150">
        <items id="text">Batch-ID</items>
        <items id="description">Identifikatoren tilordnet av produsenten for å identifisere produksjons-batchen for produktet.</items>
      </items>
      <items code="at0151">
        <items id="text">Produsent</items>
        <items id="description">Produsenten av komponenten.</items>
        <items id="comment">For eksempel "Abbott".</items>
      </items>
      <items code="at0152">
        <items id="text">Styrke (presentasjon)</items>
        <items id="description">Styrken av legemiddelet eller legemiddelkomponenten, angitt som en brøk.</items>
        <items id="comment">I noen tilfeller, som for flytende eller halvfaste legemidler, er nevneren i styrkebrøken en fysisk størrelse, for eksempel 2 mg/5 ml. I noen av disse tilfellene reflekterer nevneren også det faktiske volumet av komponenten: For det forrige eksempelet 5 ml. I dette tilfellet ville "Styrke (konsentrasjon)" vært 0,4 mg/ml. I andre tilfeller, der styrken involverer en nevner som ikke er en fysisk størrelse, for eksempel 4 mg/tablett, uttrykkes nevneren som verdien "1", med enheten "tablett". Dette mønsteret ble valgt som en tilpasning til ISO IDMP-standarden. For eksempel 4 mg/tablett, 2 mg/5 ml, 100 mg/dose. Dersom elementet "Styrke (konsentrasjon)" brukes, er dette clusteret overflødig.</items>
      </items>
      <items code="at0153">
        <items id="text">Styrketeller</items>
        <items id="description">Telleren i styrkebrøken.</items>
        <items id="comment">For eksempel: For en presentasjonsstyrke på "300 µg/0,3 ml", er Styrketeller "300 µg". For en presentasjonsstyrke på "100 mg/tablett", er Styrketeller "100 mg".</items>
      </items>
      <items code="at0157">
        <items id="text">Styrkenevner</items>
        <items id="description">Nevneren i styrkebrøken.</items>
        <items id="comment">For eksempel: For en presentasjonsstyrke på "300 µg/0,3 ml", er Styrkenevner "0,3 ml". For en presentasjonsstyrke på "100 mg/tablett", er Styrkenevner "1 tablett".</items>
      </items>
    </term_definitions>
    <term_definitions language="pt">
      <items code="at0000">
        <items id="text">*Medication details (en)</items>
        <items id="description">*Details about a medication or component of a medication, including strength, form, and details of any specific constituents.(en)</items>
      </items>
      <items code="at0001">
        <items id="text">*Combination pack(en)</items>
        <items id="description">*The component consists of a number of separate products which are pre-packaged by the manufacturer.(en)</items>
      </items>
      <items code="at0003">
        <items id="text">*Expiry(en)</items>
        <items id="description">*The expiry date and/or time of the medication or medication component, as given by the manufacturer or individual preparing the mixture.(en)</items>
        <items id="comment">*Any other form of expiry date, such as time from production or depending on storage environment, can be inserted using a specific CLUSTER archetype in the Substance Details slot or added as part of the Description.&#xD;
 For example: '2017-05-23'.(en)</items>
      </items>
      <items code="at0071">
        <items id="text">*Form(en)</items>
        <items id="description">*The formulation or presentation of the medication or medication component.(en)</items>
        <items id="comment">*For example: 'tablet', 'capsule', 'cream', 'infusion fluid' or 'inhalation powder'. Coding of the form with a terminology is preferred, where possible. Medicines catalogues may differentiate between administrable form 'solution for injection' and product form 'powder for solution for injection'. The recorded form will depend on the exact context of use but administrable form is likely to be used in most instances.(en)</items>
      </items>
      <items code="at0080">
        <items id="text">Terapêutico</items>
        <items id="description">Este elemento químico tem um efeito conhecido e considerado como positivo.</items>
      </items>
      <items code="at0083">
        <items id="text">Coadjuvante</items>
        <items id="description">Este elemento químico é ativo mas apoia o efeito terapêutico de outro ingrediente.</items>
      </items>
      <items code="at0084">
        <items id="text">Diluente</items>
        <items id="description">Diluente inerte.</items>
      </items>
      <items code="at0115">
        <items id="text">*Strength (concentration)(en)</items>
        <items id="description">*The strength of the medication or medication component, as a concentration.(en)</items>
        <items id="comment">*This element is used for liquid or semisolid medications, or medications intended to be diluted in a liquid before administration. For example: '10 mg/ml', '20 mg/g', '5 %', '10,000 SQ-U/ml'. If the 'Strength (presentation)' cluster is used, this element becomes redundant. (en)</items>
      </items>
      <items code="at0127">
        <items id="text">*Role(en)</items>
        <items id="description">*The role of the constituent within the mixture or infusion.(en)</items>
      </items>
      <items code="at0132">
        <items id="text">*Name(en)</items>
        <items id="description">*The name of the medication or medication component.(en)</items>
        <items id="comment">*For example: 'Zinacef 750 mg powder' or 'cefuroxim'. This item should be coded if possible, using for example, RxNorm, DM+D, Australian Medicines Terminology or FEST. Usage of this element will vary according to context of use. This element may be omitted where the name of the medication is recorded in the parent INSTRUCTION or ACTION archetype, and this archetype is only used to record that the form must be or was 'liquid'.(en)</items>
      </items>
      <items code="at0133">
        <items id="text">*Description(en)</items>
        <items id="description">*Narrative description of the medication or medication component where it is not possible to describe this fully using structured elements.(en)</items>
      </items>
      <items code="at0138">
        <items id="text">*Constituent details(en)</items>
        <items id="description">*Details of the constituent.(en)</items>
      </items>
      <items code="at0139">
        <items id="text">*Amount(en)</items>
        <items id="description">*The amount of medication or medication component. (en)</items>
        <items id="comment">*For example: '1 ml', '1.5 mg', '1000 ml'.  (en)</items>
      </items>
      <items code="at0141">
        <items id="text">*Structured details(en)</items>
        <items id="description">*Additional details about the medication or medication component.(en)</items>
        <items id="comment">*For example: detailed information about the drug class or intended routes, or additional expiry information.(en)</items>
      </items>
      <items code="at0142">
        <items id="text">*Category(en)</items>
        <items id="description">*The category of the medication or medication component, with regard to manufacturing or preparation, and the number of ingredients.(en)</items>
        <items id="comment">*For example: 'Paracetamol/codeine' is a Multi-ingredient product, while 'Morphine 60 mg + Haloperidol 2 mg + Midazolam 5 mg' is an Ad-hoc mixture, whose composition is fully specified within the order.(en)</items>
      </items>
      <items code="at0143">
        <items id="text">*Ad-hoc mixture(en)</items>
        <items id="description">*The component is composed of a mixture of ingredients specified within the order.(en)</items>
      </items>
      <items code="at0144">
        <items id="text">*Multi-ingredient product(en)</items>
        <items id="description">*The medication or medication component consists of a number of active ingredients which are pre-combined into a single form such as a tablet, cream or powder by the manufacturer, for example Paracetamol/codeine.(en)</items>
      </items>
      <items code="at0145">
        <items id="text">*Single-substance product(en)</items>
        <items id="description">*The component is a manufactured product containing a single ingredient.(en)</items>
      </items>
      <items code="at0146">
        <items id="text">*Ingredient(en)</items>
        <items id="description">*The medication or medication component is an individual ingredient of the medication. This term is used when the archetype is nested within a parent instance of itself, to describe the individual ingredients of a medication.(en)</items>
      </items>
      <items code="at0148">
        <items id="text">*Alternate amount(en)</items>
        <items id="description">*An equivalent representation of the amount of the medication or medication component. (en)</items>
        <items id="comment">*For example: for a medication with a strength of '5 mg/ml' and where the Amount is '1 ml', and the value recorded in this data element would be '5 mg'. (en)</items>
      </items>
      <items code="at0150">
        <items id="text">*Batch ID(en)</items>
        <items id="description">*The identifier assigned to the batch of medications by the manufacturer during production.(en)</items>
      </items>
      <items code="at0151">
        <items id="text">*Manufacturer(en)</items>
        <items id="description">*The manufacturer of the component.(en)</items>
        <items id="comment">*For example: 'Abbott'.(en)</items>
      </items>
      <items code="at0152">
        <items id="text">*Strength (presentation)(en)</items>
        <items id="description">*The strength of the medication or medication component, expressed as a ratio.(en)</items>
        <items id="comment">*In some cases, as for liquid or semisolid medications, the denominator of the strength ratio is a physical quantity, for example 2 mg/5 ml. In some of these cases the denominator also reflects the actual volume of the component: 5 ml in the previous example. In this case the 'Strength (concentration)' would be 0.4 mg/ml. In other cases, where the strength involves a denominator which is not a physical quantity, for example 4 mg/tablet, the denominator is expressed as a unitary value '1' with a unit of '1', and 'tablet' is carried in the 'Unit of presentation' element. This arrangement was chosen to align with the approach adopted by the ISO IDMP standard for medication catalogues. If the 'Strength (concentration)' element is used, this cluster becomes redundant. (en)</items>
      </items>
      <items code="at0153">
        <items id="text">*Strength numerator(en)</items>
        <items id="description">*The numerator of the strength fraction. (en)</items>
        <items id="comment">*For example: For a presentation strength of '300 µg/0.3 ml', the strength numerator is '300 µg'. For a presentation strength of '100 mg/tablet', the strength numerator value is '100 mg'. (en)</items>
      </items>
      <items code="at0157">
        <items id="text">*Strength denominator(en)</items>
        <items id="description">*The denominator of the strength fraction. (en)</items>
        <items id="comment">*For example: For a presentation strength of '300 µg/0.3 ml', the strength denominator value is '0.3 ml'. For a presentation strength of '100 mg/tablet', the strength denominator value is '1 tablet'. (en)</items>
      </items>
    </term_definitions>
    <term_definitions language="de">
      <items code="at0000">
        <items id="text">Arzneimittel</items>
        <items id="description">Angaben über ein Arzneimittel oder eine Arzneimittelkomponente, einschließlich der Wirkstärke, der Darreichungsform und Informationen über spezifische Bestandteile.</items>
      </items>
      <items code="at0001">
        <items id="text">Kombinationsprodukt</items>
        <items id="description">Das Arzneimittel oder die Arzneimittelkomponente besteht aus einer Reihe von separaten Produkten, die vom Hersteller vorverpackt werden, z.B. Canesten Combi.</items>
      </items>
      <items code="at0003">
        <items id="text">Verfallsdatum</items>
        <items id="description">Das Verfallsdatum und/oder die Verfallszeit des Arzneimittels oder der Arzneimittelkomponente. Diese Angabe wird vom Hersteller oder einer Person während der Mixtur-Zubereitung gemacht.</items>
        <items id="comment">Jegliche andere Formen des Verfallsdatums, wie z.B. die Zeit ab Produktion oder Abhängigkeiten von der Lagerumgebung, können in einem spezifischen CLUSTER-Archetyp aufgenommen werden. Darüber hinaus können diese Angaben auch in einem SLOT, der Details über die Substanz dokumentiert, oder als Teil einer Beschreibung erfasst werden. Zum Beispiel: "23.05.2017".</items>
      </items>
      <items code="at0071">
        <items id="text">Darreichungsform</items>
        <items id="description">Die Zubereitung oder die Darstellung eines Arzneimittels oder einer Arzneimittelkomponente.</items>
        <items id="comment">Zum Beispiel: "Tablette", "Kapsel", "Creme", "Infusionslösung" oder "Inhalationspulver". Die Codierung der Darreichungsform mit einer Terminologie wird, sofern dies möglich ist, bevorzugt. Die Arzneimittelkataloge können zwischen der Form zur Verabreichung "Injektionslösung" und der Form des Produktes "Pulver zur Zubereitung der Injektionslösung" unterscheiden. Die dargestellte Form hängt vom Kontext der Anwendung ab. Es wird meist jedoch die Verabreichungsform verwendet.</items>
      </items>
      <items code="at0080">
        <items id="text">Wirkstoff</items>
        <items id="description">Bestandteil, der allein oder in Kombination mit einem oder mehreren anderen Inhaltsstoffen die beabsichtigte Wirkung eines Arzneimittels erfüllt.</items>
      </items>
      <items code="at0083">
        <items id="text">Hilfsstoff</items>
        <items id="description">Ein Bestandteil mit der primären Funktion, die Wirkung des aktiven Bestandteils zu verändern. Ein unterstützender (adjuvant) Bestandteil kann selbst therapeutisch wirksam sein, muss es aber nicht.</items>
      </items>
      <items code="at0084">
        <items id="text">Sonstiger Bestandteil</items>
        <items id="description">Bestandteil, der in Bezug auf die beabsichtigte Wirkung des Arzneimittels unbeteiligt ist.</items>
      </items>
      <items code="at0115">
        <items id="text">Wirkstoffkonzentration</items>
        <items id="description">Die Wirkstärke eines Arzneimittels oder einer Arzneimittelkomponente als Konzentration.</items>
        <items id="comment">Dieses Element wird für Flüssigkeiten, halbfesten Arzneimitteln oder Arzneimitteln, die vor der Verabreichung in einer Flüssigkeit gelöst werden müssen, verwendet. Zum Beispiel: "10 mg/ml", "20 mg/g", "5 %", "10,000 SQ-U/ml". Wird der Cluster "Wirkstärke (Darreichungsform)" verwendet, wird dieses Element überflüssig.</items>
      </items>
      <items code="at0127">
        <items id="text">Funktion</items>
        <items id="description">Die Funktion eines Arzneimittels oder einer Arzneimittelkomponente innerhalb einer Mixtur.</items>
      </items>
      <items code="at0132">
        <items id="text">Name</items>
        <items id="description">Der Name des Arzneimittels oder der Arzneimittelkomponente.</items>
        <items id="comment">Zum Beispiel: "Zinacef 750 mg Puder" oder "Cefuroxim". Dieses Item sollte möglichst codiert werden, z.B. mittels RxNorm, DM+D, Australian Medicines Terminology oder FEST. Die Verwendung dieses Elements variiert je nach Anwendungskontext. Dieses Element kann weggelassen werden, wenn der Name des Arzneimittels in dem übergeordneten INSTRUCTION- oder ACTION-Archetyp vorhanden ist, und dieser Archetyp nur zur Darstellung der Darreichungsform genutzt wird, z.B. "Flüssigkeit".</items>
      </items>
      <items code="at0133">
        <items id="text">Beschreibung</items>
        <items id="description">Eine Möglichkeit zur Beschreibung des Arzneimittels oder der Arzneimittelkomponente, wenn dies nicht mit vollständig strukturierten Elementen möglich war.</items>
      </items>
      <items code="at0138">
        <items id="text">Bestandteil</items>
        <items id="description">Angaben zu einem Inhaltsstoff oder Produkt, das zur Herstellung einer Mischpackung, eines Präparats oder einer Infusion verwendet wird.</items>
        <items id="comment">Dieser Slot ist dazu gedacht, dem Archetyp Details über Bestandteile des Arzneimittels oder der Arzneimittelkomponente unter Verwendung verschachtelter Instanzen hinzuzufügen. Dies ist in der Regel nur dann erforderlich, wenn eine Mixtur beschrieben wird.</items>
      </items>
      <items code="at0139">
        <items id="text">Menge</items>
        <items id="description">Die Menge des Arzneimittels oder der Arzneimittelkomponente.</items>
        <items id="comment">Zum Beispiel: "1 ml", "1,5 mg", "1000 ml".</items>
      </items>
      <items code="at0141">
        <items id="text">Strukturierte Angaben</items>
        <items id="description">Zusätzliche Angaben über das Arzneimittel oder die Arzneimittelkomponente.</items>
        <items id="comment">Zum Beispiel: Detaillierte Informationen über Wirkstoffgruppe oder vorgesehene Verabreichungswege, oder zusätzliche Informationen zum Verfallsdatum.</items>
      </items>
      <items code="at0142">
        <items id="text">Kategorie</items>
        <items id="description">Die Kategorie des Arzneimittels oder der Arzneimittelkomponente, hinsichtlich der Herstellung oder Zubereitung und der Anzahl der Inhaltsstoffe.</items>
        <items id="comment">Zum Beispiel: "Paracetamol/Codein" ist ein Produkt mit mehreren Inhaltsstoffen, im Gegensatz dazu ist "Morphin 60 mg + Haloperidol 2 mg + Midazolam 5 mg" eine Ad-hoc-Mixtur, deren Zusammensetzung innerhalb der Verordnung spezifiziert wird.</items>
      </items>
      <items code="at0143">
        <items id="text">Ad-hoc Mixtur</items>
        <items id="description">Das Arzneimittel oder die Arzneimittelkomponente besteht aus einer Mischung von Inhaltsstoffen, die in der Verordnung angegeben sind. Diese werden in der Regel von Apotheken- oder Stationspersonal individuell für den Patienten zubereitet.</items>
      </items>
      <items code="at0144">
        <items id="text">Produkt mit meheren Inhaltsstoffen</items>
        <items id="description">Das Arzneimittel oder die Arzneimittelkomponente besteht aus einer Reihe von Wirkstoffen, die vom Hersteller in einer Darreichungsform, wie z.B. als eine Tablette, Creme oder ein Pulver, zusammengesetzt werden. Ein Beispiel hierfür ist Paracetamol/Codein.</items>
      </items>
      <items code="at0145">
        <items id="text">Produkt mit einem Inhaltsstoff</items>
        <items id="description">Das Arzneimittel oder die Arzneimittelkomponente ist ein hergestelltes Produkt, das einen einzigen Wirkstoff enthält.</items>
      </items>
      <items code="at0146">
        <items id="text">Inhaltsstoff</items>
        <items id="description">Das Arzneimittel oder die Arzneimittelkomponente ist ein einzelner Inhaltsstoff des Arzneimittels. Dieser Begriff wird verwendet, wenn der Archetyp innerhalb einer übergeordneten Instanz seines eigenen Archetyps verschachtelt ist, um die einzelnen Bestandteile eines Arzneimittels zu beschreiben.</items>
      </items>
      <items code="at0148">
        <items id="text">Alternative Menge</items>
        <items id="description">Der Wert einer äquivalenten Darstellung der Menge des Arzneimittels oder der Arzneimittelkomponente.</items>
        <items id="comment">Beispiel: Für ein Arzneimittel mit einer Wirkstoffkonzentration von "5 mg/ml" und einer Menge von "1 ml" und der in diesem Datenelement aufgezeichnete Wert wäre "5 mg".</items>
      </items>
      <items code="at0150">
        <items id="text">Batch ID</items>
        <items id="description">Die Kennung der Produktionscharge, die vom Hersteller während der Produktion zugewiesen wird.</items>
      </items>
      <items code="at0151">
        <items id="text">Hersteller</items>
        <items id="description">Der Hersteller des Arzneimittels oder der Arzneimittelkomponente.</items>
        <items id="comment">Zum Beispiel: "Abbott".</items>
      </items>
      <items code="at0152">
        <items id="text">Wirkstärke (Darreichungsform)</items>
        <items id="description">Die Wirkstärke des Arzneimittels oder der Arzneimittelkomponente, ausgedrückt als Verhältniszahl.</items>
        <items id="comment">In einigen Fällen, wie bei flüssigen oder halbfesten Arzneimitteln, ist der Nenner des Stärkeverhältnisses eine physikalische Größe, zum Beispiel 2 mg/5 ml. In einigen dieser Fälle spiegelt der Nenner auch das tatsächliche Volumen der Komponente wider: 5 ml im vorherigen Beispiel. In diesem Fall würde die "Wirkstoffkonzentration" 0,4 mg/ml betragen. In anderen Fällen, wenn die Stärke einen Nenner betrifft, der keine physikalische Größe ist, z.B. 4 mg/Tablette, wird der Nenner als einheitlicher Wert "1" mit einer Einheit "1" ausgedrückt, und "Tablette" wird im Element "Einheit der Darreichungsform" geführt. Diese Regelung wurde gewählt, um dem Ansatz der ISO IDMP-Norm für Medikamentenkataloge gerecht zu werden. Wird das Element "Wirkstoffkonzentration" verwendet, wird dieser Cluster überflüssig.</items>
      </items>
      <items code="at0153">
        <items id="text">Wirkstärke (Zähler)</items>
        <items id="description">Der Wert des Zählers des Wirkstärkeanteils.</items>
        <items id="comment">Zum Beispiel: Lautet die Wirkstärke (Darreichungsform) "300 µg/0,3 ml", so beträgt die Wirkstärke (Zähler) "300 µg". Bei einer Wirkstärke (Darreichungsform) von "100 mg/Tablette" ist der Wirkstärke-Zähler "100 mg".</items>
      </items>
      <items code="at0157">
        <items id="text">Wirkstärke (Nenner)</items>
        <items id="description">Der Wert des Nenners des Wirkstärkeanteils.</items>
        <items id="comment">Zum Beispiel: Der Wert des Nenners der Wirkstärke (Darreichungsform) "300 µg/0,3 ml" ist "0,3 ml". Der Wert des Nenners der Wirkstärke "100 mg/Tablette" ist "1 Tablette".</items>
      </items>
    </term_definitions>
    <term_definitions language="nl">
      <items code="at0000">
        <items id="text">*Medication details (en)</items>
        <items id="description">Gegevens over een medicament of onderdeel van een medicament, inclusief dosis, vorm en details over een specifiek bestandsdeel.</items>
      </items>
      <items code="at0001">
        <items id="text">Combinatie product</items>
        <items id="description">Het medicament of medicatie bestanddeel bestaat uit een aantal onafhankelijke producten die voorverpakt zijn door de fabrikant, bijvoorbeeld 'Canesten Combi'.</items>
      </items>
      <items code="at0003">
        <items id="text">Houdbaarheid</items>
        <items id="description">De houdbaarheidsdatum en/of tijd van het medicament of medicatie bestanddeel, zoals bepaald door de fabrikant of het individu dat het mengsel bereidt.</items>
        <items id="comment">*Any other form of expiry date, such as time from production or depending on storage environment, can be inserted using a specific CLUSTER archetype in the Substance Details slot or added as part of the Description.&#xD;
 For example: '2017-05-23'. (en)</items>
      </items>
      <items code="at0071">
        <items id="text">Vorm</items>
        <items id="description">De vorm waarin het medicament of medicatie bestandsdeel aangeboden wordt.</items>
        <items id="comment">Bijvoorbeeld: 'tablet', 'capsule', 'creme', 'infusie vloeistof' of 'inhalatie poeder'. Coderen van de vorm met een terminology verdient de voorkeur, indien mogelijk. Medicatie formularia kunnen onderscheid maken tussen vormen die toegediend kunnen worden: 'oplossing voor injectie' en productvormen: 'poeder voor oplossing voor injectie'. De vastgelegde vorm zal afhangen van de specifieke gebruikscontext maar toedienbare vorm zal waarschijnlijk het meest gebruikt worden.</items>
      </items>
      <items code="at0080">
        <items id="text">Therapeuticum</items>
        <items id="description">*Constituent that alone or in combination with one or more other ingredients is considered to fulfil the intended activity of a medicinal product. (en)</items>
      </items>
      <items code="at0083">
        <items id="text">Adjuvans</items>
        <items id="description">*Constituent whose primary function is to modify the activity of an active constituent. An adjuvant constituent itself may or may not be therapeutically active.</items>
      </items>
      <items code="at0084">
        <items id="text">*Excipient (en)</items>
        <items id="description">*Constituent that is inert in relation to the intended activity of the medicinal product. (en)</items>
      </items>
      <items code="at0115">
        <items id="text">Dosis (concentratie)</items>
        <items id="description">*The strength of the medication or medication component, as a concentration. (en)</items>
        <items id="comment">*This element is used for liquid or semisolid medications, or medications intended to be diluted in a liquid before administration. For example: '10 mg/ml', '20 mg/g', '5 %', '10,000 SQ-U/ml'. If the 'Strength (presentation)' cluster is used, this element becomes redundant. (en)</items>
      </items>
      <items code="at0127">
        <items id="text">Rol</items>
        <items id="description">De rol van het medicament of het medicatie bestanddeel in een mengsel.</items>
      </items>
      <items code="at0132">
        <items id="text">Naam</items>
        <items id="description">De naam van het medicament of medicatie bestandsdeel.</items>
        <items id="comment">Bijvoorbeeld: 'Zinacef 750mg poeder' of 'cefuroxim'. Dit veld dient, indien mogelijk, gecodeerd te worden met behulp van bijvoorbeeld RxNorm, DM+D, Autralian Medicines Terminology, FEST of de G-Standaard. Gebruik van dit veld zal verschillen per gebruikscontext. Dit element can overgeslagen worden wanneer de naam van het medicament vastgelegd is in het bovenliggende INSTRUCTION of ACTION archetype en dit archetype zelf alleen gebruikt wordt voor het vastleggen dat de vorm 'vloeibaar' is, of dient te zijn.</items>
      </items>
      <items code="at0133">
        <items id="text">Beschrijving</items>
        <items id="description">*Narrative description of the medication or medication component where it is not possible to describe this fully using structured elements. (en)</items>
      </items>
      <items code="at0138">
        <items id="text">Bestanddeel</items>
        <items id="description">Gegevens over een bestanddeel of product als onderdeel van een gemengde strip, bereiding of infusie.</items>
        <items id="comment">*This slot is intended to be used to add details about constituents of the medication or medication component, using nested instances of this archetype. This is not normally required other than where a mixture is being described. (en)</items>
      </items>
      <items code="at0139">
        <items id="text">Hoeveelheid</items>
        <items id="description">*The amount of medication or medication component. (en)</items>
        <items id="comment">*For example: '1 ml', '1.5 mg', '1000 ml'.  (en)</items>
      </items>
      <items code="at0141">
        <items id="text">*Structured details (en)</items>
        <items id="description">*Additional details about the medication or medication component. (en)</items>
        <items id="comment">*For example: detailed information about the drug class or intended routes, or additional expiry information. (en)</items>
      </items>
      <items code="at0142">
        <items id="text">Categorie</items>
        <items id="description">De categorie van het medicament of het medicatie bestandsdeel, gerelateerd aan fabricage of bereiding en het aantal bestandsdelen.</items>
        <items id="comment">Bijvoorbeeld: 'Paracetamol/codeïne' is een combinatiepreparaat, terwijl 'Morphine 60mg + Haloperidol 2 mg +Midazolam 5 mg' een ad-hoc mix is waarvan de samenstelling in het recept wordt beschreven.</items>
      </items>
      <items code="at0143">
        <items id="text">Ad-hoc mengsel</items>
        <items id="description">Het medicament of medicatie bestandsdeel bestaat uit een mengsel van bestanddelen vastgelegd in het recept. Deze worden normaal specifiek voor een patient bereidt door apotheek- of verpleegafdelingspersoneel.</items>
      </items>
      <items code="at0144">
        <items id="text">Samengesteld product</items>
        <items id="description">Het medicament of het medicatie bestanddeel bestaat uit een aantal actieve onderdelen die in enkele vorm zoals een table, creme of poeder, bereid zijn door de fabrikant, bijvoorbeeld 'Paracetamol/codeïne'.</items>
      </items>
      <items code="at0145">
        <items id="text">Enkelvoudig productie</items>
        <items id="description">Een medicament of medicatie bestanddeel is een gefabriceerd product dat een enkel actief bestanddeel bevat.</items>
      </items>
      <items code="at0146">
        <items id="text">Bestanddeel</items>
        <items id="description">Het medicament of het medicatie bestanddeel is een enkel bestanddeel van het medicament. Deze term wordt gebruikt wanneer het archetype onderdeel is van een 'parent instance' van zichzelf, voor het beschrijven van individuele bestanddelen van een medicament.</items>
      </items>
      <items code="at0148">
        <items id="text">Alternatieve hoeveelheid</items>
        <items id="description">*An equivalent representation of the amount of the medication or medication component. (en)</items>
        <items id="comment">*For example: for a medication with a strength of '5 mg/ml' and where the Amount is '1 ml', and the value recorded in this data element would be '5 mg'. (en)</items>
      </items>
      <items code="at0150">
        <items id="text">Batch ID</items>
        <items id="description">De identificatie toegewezen aan de productie batch door de fabrikant tijdens de productie. Ook wel partij-, lot- of chargenummer genoemd.</items>
      </items>
      <items code="at0151">
        <items id="text">Fabrikant</items>
        <items id="description">De fabrikant van het medicament of medicatie bestanddeel.</items>
        <items id="comment">Bijvoorbeeld: 'Abbott'.</items>
      </items>
      <items code="at0152">
        <items id="text">Dosis (presentatie)</items>
        <items id="description">De dosis van het medicament of medicatie bestanddeel, uitgedrukt als een ratio.</items>
        <items id="comment">*In some cases, as for liquid or semisolid medications, the denominator of the strength ratio is a physical quantity, for example 2 mg/5 ml. In some of these cases the denominator also reflects the actual volume of the component: 5 ml in the previous example. In this case the 'Strength (concentration)' would be 0.4 mg/ml. In other cases, where the strength involves a denominator which is not a physical quantity, for example 4 mg/tablet, the denominator is expressed as a unitary value '1' with a unit of '1', and 'tablet' is carried in the 'Unit of presentation' element. This arrangement was chosen to align with the approach adopted by the ISO IDMP standard for medication catalogues. If the 'Strength (concentration)' element is used, this cluster becomes redundant. (en)</items>
      </items>
      <items code="at0153">
        <items id="text">Dosis teller</items>
        <items id="description">*The numerator of the strength fraction. (en)</items>
        <items id="comment">*For example: For a presentation strength of '300 µg/0.3 ml', the strength numerator is '300 µg'. For a presentation strength of '100 mg/tablet', the strength numerator value is '100 mg'. (en)</items>
      </items>
      <items code="at0157">
        <items id="text">Dosis noemer</items>
        <items id="description">*The denominator of the strength fraction. (en)</items>
        <items id="comment">*For example: For a presentation strength of '300 µg/0.3 ml', the strength denominator value is '0.3 ml'. For a presentation strength of '100 mg/tablet', the strength denominator value is '1 tablet'. (en)</items>
      </items>
    </term_definitions>
    <term_definitions language="sv">
      <items code="at0000">
        <items id="text">Läkemedelsdetaljer</items>
        <items id="description">Detaljer om ett läkemedel eller ett innehållsämne, inkluderat styrka, beredning och uppgifter om eventuella specifika beståndsdelar.</items>
      </items>
      <items code="at0001">
        <items id="text">Kombinationsförpackning</items>
        <items id="description">Läkemedlet består av ett antal separata produkter som förpackats av tillverkaren, exempelvis Canesten Combi.</items>
      </items>
      <items code="at0003">
        <items id="text">Utgångsdatum</items>
        <items id="description">Utgångsdatum eller -tidpunkt för läkemedlet eller innehållsämnet, såsom angivet av tillverkaren eller vid en individuell beredning av en blandning.</items>
        <items id="comment">För att ange annan form av utgångsdatum, till exempel tid från produktion eller beroende på lagringsmiljö, använd en specifik CLUSTER-arketyp i SLOT Substance Details eller som del i SLOT Description. Exempelvis "2025-05-23".</items>
      </items>
      <items code="at0071">
        <items id="text">Beredning</items>
        <items id="description">Beredningsformen, eller en beskrivning av läkemedlet eller innehållsämnet.</items>
        <items id="comment">Exempelvis "tablett", "kapsel", "kräm", "infusionsvätska" eller "inhalationspulver". &#xD;
Koda om möjligt beredningstypen med en terminologi. Läkemedelskataloger kan skilja mellan den direkt administrerbara beredningen "lösning för injektion" och produktberedningen "pulver för injektionsvätska", som båda är avsedda att injiceras som en lösning. Den beredningsform som registreras beror på det exakta sammanhanget vid användning. I de flesta fall används sannolikt den direkt administrerbara beredningsformen.</items>
      </items>
      <items code="at0080">
        <items id="text">Terapeutisk</items>
        <items id="description">Beståndsdel som ensam eller i kombination med en eller flera andra beståndsdelar bedöms uppfylla läkemedlets avsedda verkan.</items>
      </items>
      <items code="at0083">
        <items id="text">Adjuvant</items>
        <items id="description">Beståndsdel vars primära funktion är att modifiera effekten hos en aktiv beståndsdel. En adjuvant beståndsdel kan antingen vara terapeutiskt verksam eller inte.</items>
      </items>
      <items code="at0084">
        <items id="text">Hjälpämne</items>
        <items id="description">Beståndsdel som är overksam i förhållande till läkemedlets avsedda verkan.</items>
      </items>
      <items code="at0115">
        <items id="text">Styrka (koncentration)</items>
        <items id="description">Styrkan hos läkemedlet eller innehållsämnet, angivet som koncentration.</items>
        <items id="comment">Detta datafält används för flytande eller halvfasta läkemedel, eller läkemedel som ska lösas upp i en vätska innan administrering. Exempelvis "10 mg/ml", "20 mg/g", "5 %", "10 000 SQ-U/ml". Om klustret "Styrka (beskrivning)" används, blir detta datafält överflödigt.</items>
      </items>
      <items code="at0127">
        <items id="text">Verkningssätt</items>
        <items id="description">Verkningssättet för läkemedlet eller innehållsämnet i en blandning.</items>
      </items>
      <items code="at0132">
        <items id="text">Namn</items>
        <items id="description">Namnet på läkemedlet eller innehållsämnet.</items>
        <items id="comment">Till exempel: "Zinacef 750 mg pulver" eller "cefuroxim". Det här datafältet bör om möjligt kodas, exempelvis med RxNorm, DM+D, Australian Medicines Terminology eller FEST (anm. i Sverige används ATC-koder, NSL-id eller kod från nationella substansregistret). Användningen av detta fält varierar beroende på sammanhang. Det kan utelämnas om läkemedlets namn registreras i föräldraarketypen (INSTRUCTION eller ACTION). Arketypen används endast för att registrera att beredningen måste vara eller har varit i "flytande" form.</items>
      </items>
      <items code="at0133">
        <items id="text">Beskrivning</items>
        <items id="description">Beskrivning av läkemedlet eller innehållsämnet där det inte är möjligt att beskriva detta fullt ut med hjälp av de strukturerade datafälten.</items>
      </items>
      <items code="at0138">
        <items id="text">Beståndsdel</items>
        <items id="description">Detaljer om en beståndsdel eller produkt som används för att göra en blandad förpackning, beredning eller infusion.</items>
        <items id="comment">Använd denna SLOT för att lägga till detaljer om beståndsdelar i läkemedlet eller innehållsämnet med hjälp av nästlade instanser av denna arketyp. Detta krävs normalt endast när en blandning beskrivs.</items>
      </items>
      <items code="at0139">
        <items id="text">Mängd</items>
        <items id="description">Mängden av läkemedlet eller innehållsämnet.</items>
        <items id="comment">Exempelvis "1 ml", "1,5 mg", "1000 ml".</items>
      </items>
      <items code="at0141">
        <items id="text">Strukturerade detaljer</items>
        <items id="description">Ytterligare information om läkemedlet eller innehållsämnet.</items>
        <items id="comment">Exempelvis detaljerad information om läkemedelsklass eller avsedda administreringsvägar, eller ytterligare information om hållbarheten.</items>
      </items>
      <items code="at0142">
        <items id="text">Kategori</items>
        <items id="description">Kategorin av läkemedel eller innehållsämne, med avseende på tillverkning eller beredning samt antalet beståndsdelar.</items>
        <items id="comment">Exempelvis är "paracetamol/kodein" ett kombinationsläkemedel medan "morfin 60 mg + haloperidol 2 mg + midazolam 5 mg" är en situationsanpassad blandning vars sammansättning är fullständigt specificerad i ordinationen.</items>
      </items>
      <items code="at0143">
        <items id="text">Situationsanpassad blandning</items>
        <items id="description">Läkemedlet eller innehållsämnet består av en blandning av beståndsdelar som anges i ordinationen. Dessa bereds vanligtvis av apotek eller avdelningspersonal för att anpassas till enskilda patienter.</items>
      </items>
      <items code="at0144">
        <items id="text">Kombinationsläkemedel</items>
        <items id="description">Läkemedlet eller innehållsämnet består av ett antal aktiva substanser som är förblandade till en enda beredningsform av tillverkaren, såsom en tablett, en kräm eller pulver, exempelvis paracetamol/kodein.</items>
      </items>
      <items code="at0145">
        <items id="text">Singelsubstansprodukt</items>
        <items id="description">Läkemedlet eller innehållsämnet är en tillverkad produkt som innehåller en enda aktiv substans.</items>
      </items>
      <items code="at0146">
        <items id="text">Beståndsdel</items>
        <items id="description">Läkemedlet eller innehållsämnet är en enskild beståndsdel i läkemedlet. Denna term används när arketypen är nästlad i en föräldrainstans av sig själv för att beskriva de enskilda beståndsdelarna i ett läkemedel.</items>
      </items>
      <items code="at0148">
        <items id="text">Alternativ mängd</items>
        <items id="description">Ett likvärdigt sätt att beskriva mängden av läkemedlet eller innehållsämnet.</items>
        <items id="comment">För ett läkemedel med exempelvis styrkan "5 mg/ml" där mängden är "1 ml" blir värdet som registreras i detta fält "5 mg".</items>
      </items>
      <items code="at0150">
        <items id="text">Batch-ID</items>
        <items id="description">Den identifierare som tillverkaren tilldelat batchen under produktionen.</items>
      </items>
      <items code="at0151">
        <items id="text">Tillverkare</items>
        <items id="description">Tillverkaren av läkemedlet eller innehållsämnet.</items>
        <items id="comment">Exempelvis "Abbott".</items>
      </items>
      <items code="at0152">
        <items id="text">Styrka (beskrivning)</items>
        <items id="description">Styrkan hos läkemedlet eller innehållsämnet, uttryckt som en fraktion.</items>
        <items id="comment">I vissa fall, som vid flytande eller halvfasta läkemedel, är nämnaren i styrkefraktionen en fysisk kvantitet, till exempel "2 mg/5 ml". Ibland representerar nämnaren också den faktiska volymen av innehållsämnet (5 ml i exemplet ovan). I detta fall skulle "Styrka (koncentration)" vara "0,4 mg/ml". I andra fall då styrkan innefattar en nämnare som inte är en fysisk storhet, till exempel "4 mg/tablett", så är nämnaren uttryckt som enhetsvärdet "1" med värdet "tablett". Denna representation används för att överensstämma med den metod som antagits av ISO-IDMP-standarden för läkemedelskataloger. Om datafältet "Styrka (koncentration)" används blir detta kluster överflödigt.</items>
      </items>
      <items code="at0153">
        <items id="text">Styrka i täljare</items>
        <items id="description">Täljaren i styrkefraktionen.</items>
        <items id="comment">För en styrkeangivelse på exempelvis "300 µg/0,3 ml" är täljaren i styrkefraktionen "300 µg". För en styrkeangivelse på "100 mg/tablett" är täljaren i styrkefraktionen "100 mg".</items>
      </items>
      <items code="at0157">
        <items id="text">Styrka i nämnare</items>
        <items id="description">Nämnaren i styrkefraktionen.</items>
        <items id="comment">För en styrkeangivelse på exempelvis "300 µg/0,3 ml" är nämnaren i styrkefraktionen "0,3 ml". För en styrkeangivelse på "100 mg/tablett" är nämnaren i styrkefraktionen "1 tablett".</items>
      </items>
    </term_definitions>
    <term_definitions language="ca">
      <items code="at0000">
        <items id="text">Detalls de la medicació</items>
        <items id="description">Dades sobre un medicament o un component d'un medicament, inclosa la concentració, la forma i els detalls de qualsevol component específic.</items>
      </items>
      <items code="at0001">
        <items id="text">Producte combinat</items>
        <items id="description">El medicament o component del medicament consisteix en una sèrie de productes independents preenvasats pel fabricant, per exemple Canesten Combi.</items>
      </items>
      <items code="at0003">
        <items id="text">Caducitat</items>
        <items id="description">La data i/o hora de caducitat del medicament o del component del medicament, indicades pel fabricant o la persona que prepara la barreja.</items>
        <items id="comment">Qualsevol altra forma de data de caducitat, com el temps transcorregut des de la producció o en funció de l'entorn d'emmagatzematge, es pot inserir utilitzant un arquetip de tipus CLUSTER específic a l'slot Detalls de la substància o afegir-se com a part de la Descripció. Per exemple: "2017-05-23".</items>
      </items>
      <items code="at0071">
        <items id="text">Forma farmacèutica</items>
        <items id="description">La formulació o presentació del medicament o component del medicament.</items>
        <items id="comment">Per exemple: "comprimit", "càpsula", "crema", "líquid per a infusió" o "pols per a inhalació". Sempre que sigui possible és preferible codificar la forma amb una terminologia. Els catàlegs de medicaments poden diferenciar entre la forma administrable "solució injectable" i la forma de producte "pols per a solució injectable". La forma registrada dependrà del context exacte dús, però és probable que sutilitza la forma administrable en la majoria dels casos.</items>
      </items>
      <items code="at0080">
        <items id="text">Terapèutic</items>
        <items id="description">Constituent que només o en combinació amb un o més ingredients es considera que compleix l'activitat prevista d'un medicament.</items>
      </items>
      <items code="at0083">
        <items id="text">Adjuvant</items>
        <items id="description">Constituent de la qual la funció principal és modificar l'activitat d'un constituent actiu. Un component adjuvant pot ser terapèuticament actiu o no.</items>
      </items>
      <items code="at0084">
        <items id="text">Excipient</items>
        <items id="description">Constituent inert en relació amb l'activitat prevista del medicament.</items>
      </items>
      <items code="at0115">
        <items id="text">Dosi (concentració)</items>
        <items id="description">La dosi del medicament o component del medicament, en forma de concentració.</items>
        <items id="comment">Aquest element es fa servir per a medicaments líquids o semisòlids, o medicaments destinats a diluir-se en un líquid abans de la seva administració. Per exemple: “10 mg/ml”, “20 mg/g”, “5 %”, “10.000 SQ-U/ml”. Si utilitzeu el grup "Dosi (presentació)", aquest element és redundant.</items>
      </items>
      <items code="at0127">
        <items id="text">Rol (funció)</items>
        <items id="description">El paper que juga el medicament o component del medicament dins una barreja.</items>
      </items>
      <items code="at0132">
        <items id="text">Nom</items>
        <items id="description">Nom del medicament o del component del medicament.</items>
        <items id="comment">Per exemple: "Zinacef 750 mg pols" o "cefuroxima". Aquest element s'ha de codificar, si és possible, utilitzant, per exemple, RxNorm, DM+D, Australian Medicines Terminology o FEST. La utilització daquest element variarà segons el context d'ús. Aquest element es pot ometre quan el nom del medicament es registri a l'arquetip principal INSTRUCTION o ACTION, i aquest arquetip només s'utilitzi per registrar que la forma ha de ser o era "líquida".</items>
      </items>
      <items code="at0133">
        <items id="text">Descripció</items>
        <items id="description">Descripció narrativa del medicament o del component del medicament quan no sigui possible descriure'l completament mitjançant elements estructurats.</items>
      </items>
      <items code="at0138">
        <items id="text">Constituent</items>
        <items id="description">Dades d'un ingredient o producte utilitzat per compondre un envàs mixt, un preparat o una infusió.</items>
        <items id="comment">Aquest slot està pensat per afegir detalls sobre el component o components del medicament, utilitzant instàncies imbricades d'aquest arquetip. Normalment no cal, excepte quan es descriu una barreja.</items>
      </items>
      <items code="at0139">
        <items id="text">Quantitat</items>
        <items id="description">Quantitat de medicament o component del medicament.</items>
        <items id="comment">Per exemple: “1 ml”, “1,5 mg”, “1000 ml”.</items>
      </items>
      <items code="at0141">
        <items id="text">Detalls estructurats</items>
        <items id="description">Detalls addicionals sobre el medicament o el component del medicament.</items>
        <items id="comment">Per exemple: informació detallada sobre la classe de medicament o les vies dadministració previstes, o informació addicional sobre la caducitat.</items>
      </items>
      <items code="at0142">
        <items id="text">Categoria</items>
        <items id="description">La categoria del medicament o component del medicament, pel que fa a la fabricació o la preparació, i el nombre d'ingredients.</items>
        <items id="comment">Per exemple: "Paracetamol/codeïna" és un producte multiingredient, mentre que "Morfina 60 mg + Haloperidol 2 mg + Midazolam 5 mg" és una barreja ad hoc, la composició del qual està totalment especificada a l'ordre.</items>
      </items>
      <items code="at0143">
        <items id="text">Barreja ad hoc</items>
        <items id="description">El medicament o el component del medicament es compon d'una barreja d'ingredients especificats a l'ordre. Normalment els prepara el personal de farmàcia o de la sala per adaptar-los a cada pacient.</items>
      </items>
      <items code="at0144">
        <items id="text">Producte amb diversos ingredients</items>
        <items id="description">El medicament o component del medicament consisteix en una sèrie de principis actius que el fabricant combina prèviament en una forma única, com ara un comprimit, una crema o una pols, per exemple Paracetamol/codeïna.</items>
      </items>
      <items code="at0145">
        <items id="text">Producte monocomponent</items>
        <items id="description">El medicament o component del medicament és un producte manufacturat que conté un únic principi actiu.</items>
      </items>
      <items code="at0146">
        <items id="text">Ingredient</items>
        <items id="description">El medicament o component del medicament és un ingredient individual del medicament. Aquest terme s'utilitza quan l'arquetip està imbricat dins d'una instància pare de si mateix, per descriure els ingredients individuals d'un medicament.</items>
      </items>
      <items code="at0148">
        <items id="text">Quantitat alternativa</items>
        <items id="description">Una representació equivalent de la quantitat de medicament o component del medicament.</items>
        <items id="comment">Per exemple: per a un medicament amb una concentració de "5 mg/ml" i on la quantitat és "1 ml", el valor registrat en aquest element de dades seria "5 mg".</items>
      </items>
      <items code="at0150">
        <items id="text">ID de lot</items>
        <items id="description">Identificador assignat al lot de producció pel fabricant durant la fabricació.</items>
      </items>
      <items code="at0151">
        <items id="text">Fabricant</items>
        <items id="description">El fabricant del medicament o del component del medicament.</items>
        <items id="comment">Per exemple: 'Abbott'.</items>
      </items>
      <items code="at0152">
        <items id="text">Dosi (presentació)</items>
        <items id="description">La dosi del medicament o del component del medicament, expressada en forma de proporció.</items>
        <items id="comment">En alguns casos, com per als medicaments líquids o semisòlids, el denominador de proporció de dosi és una quantitat física, per exemple 2 mg/5 ml. En alguns casos, el denominador també reflecteix el volum real del component: 5 ml a l'exemple anterior. En aquest cas, la "Dosi (concentració)" seria de 0,4 mg/ml. En altres casos, quan la dosi implica un denominador que no és una quantitat física, per exemple 4 mg/comprimit, el denominador s'expressa com un valor unitari “1” amb una unitat de “comprimit”. Aquesta disposició s'ha optat per ajustar-se a l'enfocament adoptat per la norma ISO IDMP per als catàlegs de medicaments. Si utilitzeu l'element "Dosi (concentració)", aquest grup és redundant.</items>
      </items>
      <items code="at0153">
        <items id="text">Numerador de dosi</items>
        <items id="description">El numerador de la fracció de dosi.</items>
        <items id="comment">Per exemple: Per a una dosi de presentació de "300 µg/0,3 ml", el numerador de dosi és "300 µg". Per a una dosi de presentació de "100 mg/tauleta", el valor del numerador de dosi és "100 mg".</items>
      </items>
      <items code="at0157">
        <items id="text">Denominador de dosi</items>
        <items id="description">El denominador de la fracció de dosi.</items>
        <items id="comment">Per exemple: Per a una dosi de presentació de “300 µg/0,3 ml”, el denominador de la dosi serà “0,3 ml”. Per a una dosi de presentació de "100 mg/comprimit", el valor del denominador de dosi és "1 comprimit".</items>
      </items>
    </term_definitions>
    <term_definitions language="es">
      <items code="at0000">
        <items id="text">Detalles de la medicación</items>
        <items id="description">Detalles sobre el medicamento o componente de un medicamento, incluido la dosis, forma o detalles de cualquier otro componente específico.</items>
      </items>
      <items code="at0001">
        <items id="text">Producto combinado</items>
        <items id="description">El medicamento o componente del medicamento consiste en un número separado de productos independientes previamente envasados por el fabricante; por ejemplo, Canesten Combi.</items>
      </items>
      <items code="at0003">
        <items id="text">Caducidad</items>
        <items id="description">La fecha y/u hora de caducidad del medicamento o componente del medicamento, indicadas por el fabricante o la persona que prepara la mezcla.</items>
        <items id="comment">Cualquier otra forma de fecha de caducidad, como el tiempo transcurrido desde la producción o en función del entorno de almacenaje, se puede inserir utilizando un arquetipo tipo CLUSTER específico en la pestaña de "Datos de la substancia" o se puede añadir como parte de la Descripción. Por ejemplo: "23/05/2017".</items>
      </items>
      <items code="at0071">
        <items id="text">Forma farmacéutica</items>
        <items id="description">La formulación o presentación del medicamento o componente del medicamento.</items>
        <items id="comment">Por ejemplo: "comprimidos", "cápsulas", "crema", "líquido para infusión" o "polvo para inhalación". Se recomienda codificar la forma farmacéutica con una terminología cuando sea posible. Los catálogos de medicamentos pueden diferenciar entre forma administrable "solución inyectable" y la forma del productor "polvo para una solución inyectable". La forma registrada dependerá del contexto exacto de uso, pero es probable que se utilice la forma administrable en la mayoría de los casos.</items>
      </items>
      <items code="at0080">
        <items id="text">Terapéutico</items>
        <items id="description">Componente que a solas o en combinación con uno o más ingredientes se considera que cumple la actividad prevista de un medicamento.</items>
      </items>
      <items code="at0083">
        <items id="text">Adyuvante</items>
        <items id="description">Componente del cual la función principal es modificar la actividad de un principio activo. Un componente adyuvante puede ser terapéuticamente activo o no.</items>
      </items>
      <items code="at0084">
        <items id="text">Excipiente</items>
        <items id="description">Componente inerte en relación con la actividad prevista del medicamento.</items>
      </items>
      <items code="at0115">
        <items id="text">Dosis (concentración)</items>
        <items id="description">La dosis del medicamento o componente del medicamento, en forma de concentración.</items>
        <items id="comment">Este elemento se utiliza para un medicamento líquido o semisólido, o medicamentos destinados a diluirse en un líquido antes de su administración. Por ejemplo: "10 mg/ml", "20 mg/g", "5%", "10.000 SQ-U/ml". Si se utiliza el grupo "Dosis (presentación)", este elemento se vuelve redundante.</items>
      </items>
      <items code="at0127">
        <items id="text">Función</items>
        <items id="description">La función del medicamento o componente del medicamento dentro de una mezcla.</items>
      </items>
      <items code="at0132">
        <items id="text">Nombre</items>
        <items id="description">Nombre del medicamento o componente del medicamento.</items>
        <items id="comment">Por ejemplo: "Zinacef 750 mg en polvo" o "cefuroxima". Si es posible, codificar el elemento, utilizando, por ejemplo, RxNorm, DM+D, Terminologia Australiana de Medicamentos or FEST. La utilización de este elemento variará según el contexto de uso. Este elemento se puede omitir cuando el nombre del medicamento se registre en el arquetipo principal de tipo INSTRUCTION o ACTION, y este arquetipo únicamente se utilice para registro que la forma ha de ser o era "líquida".</items>
      </items>
      <items code="at0133">
        <items id="text">Descripción</items>
        <items id="description">Descripción narrativa sobre el medicamento o componente del medicamento cuando no sea posible describirlo completamente mediante elementos estructurados.</items>
      </items>
      <items code="at0138">
        <items id="text">Componente</items>
        <items id="description">Detalles de un ingrediente o producto utilizado para componer un envase mixto, un preparado o una infusión.</items>
        <items id="comment">Este espacio está pensado para añadir datos sobre los componentes del medicamento o del componente del medicamento, utilizando instancias situadas de este arquetipo. Normalmente, no se requiere, excepto cuando se describe una mezcla.</items>
      </items>
      <items code="at0139">
        <items id="text">Cantidad</items>
        <items id="description">Cantidad de medicamento o componente del medicamento.</items>
        <items id="comment">Por ejemplo: "1 ml", "1.5 mg", "1000 ml".</items>
      </items>
      <items code="at0141">
        <items id="text">Detalles estructurados</items>
        <items id="description">Detalles adicionales sobre el medicamento o componente del medicamento.</items>
        <items id="comment">Por ejemplo: información detallada sobre el tipo de medicamento o las vías de administración, o información adicional sobre la caducidad.</items>
      </items>
      <items code="at0142">
        <items id="text">Categoría</items>
        <items id="description">La categoría del medicamento o componente del medicamento por lo que hace a la fabricación o preparación, y la cantidad de ingredientes.</items>
        <items id="comment">Por ejemplo: "Paracetamol/codeína" es un producto con múltiples componentes, mientras que "Morfina 60 mg + Haloperidol 2 mg + Midazolam 5 mg" es una mezcla ad hoc, la composición del cual está totalmente especificada dentro de la prescripción.</items>
      </items>
      <items code="at0143">
        <items id="text">Mezcla ad hoc</items>
        <items id="description">La medicación o componentes de la medicación consisten en una serie de principios activos que el fabricante combina previamente en una forma única, como ahora un comprimido, una crema o un polvo; por ejemplo, paracetamol/codeína.</items>
      </items>
      <items code="at0144">
        <items id="text">Producto con múltiples componentes</items>
        <items id="description">El medicamento o componente del medicamento consiste en una serie de principios activos que el fabricante combina previamente en una forma única, como ahora un comprimido o una crema en polvo; por ejemplo, paracetamol/codeína.</items>
      </items>
      <items code="at0145">
        <items id="text">Producto de un solo componente</items>
        <items id="description">El medicamento o componente del medicamento es un producto fabricado que contiene un único principio activo.</items>
      </items>
      <items code="at0146">
        <items id="text">Componente</items>
        <items id="description">La medicación o componente del medicamento es un componente individual del medicamento. Este término se utiliza cuando el arquetipo está situado dentro de una instancia principal de sí mismo para describir los componentes individuales de un medicamento.</items>
      </items>
      <items code="at0148">
        <items id="text">Cantidad alternativa</items>
        <items id="description">Una representación equivalente de la cantidad de medicamento o componente del medicamento.</items>
        <items id="comment">Por ejemplo: para un medicamento con una concentración de "5 mg/ml" y donde la Cantidad es "1 ml", el valor registrado de este elemento de datos sería "5 mg".</items>
      </items>
      <items code="at0150">
        <items id="text">Identificación del lote</items>
        <items id="description">El identificador asignado al lote de producción por el fabricante durante la fabricación del producto.</items>
      </items>
      <items code="at0151">
        <items id="text">Fabricante</items>
        <items id="description">El fabricante de la medicación o del componente de medicación.</items>
        <items id="comment">Por ejemplo: "Abbott".</items>
      </items>
      <items code="at0152">
        <items id="text">Dosis (presentación)</items>
        <items id="description">La dosis del medicamento o del componente del medicamento, expresada en forma de proporción.</items>
        <items id="comment">En algunos casos, como en los medicamentos líquidos o semisólidos, el denominador de la proporción de concentración es una cantidad física, por ejemplo, 2 mg/5 ml. En algunos de estos casos, el denominador también refleja el volumen real del componente: 5 ml en el ejemplo anterior. En este caso, la «Concentración (potencia)» sería 0,4 mg/ml. En otros casos, cuando la concentración incluye un denominador que no es una cantidad física, por ejemplo, 4 mg/comprimido, el denominador se expresa como un valor unitario '1' con la unidad 'comprimido'. Esta forma de representación se eligió para alinearse con el enfoque adoptado por la norma ISO IDMP para catálogos de medicamentos. Si se utiliza el elemento «Concentración (potencia)», este cluster se vuelve redundante.</items>
      </items>
      <items code="at0153">
        <items id="text">Numerador de dosis</items>
        <items id="description">El numerador de la fracción de dosis.</items>
        <items id="comment">Por ejemplo: para una dosis de presentación de "300 µg/0.3 ml", el valor del denominador de dosis es de "300 µg". Para una dosis de presentación de "100 mg/comprimido", el valor del denominador de dosis es de "100 mg".</items>
      </items>
      <items code="at0157">
        <items id="text">Denominador de dosis</items>
        <items id="description">El denominador de la fracción de dosis.</items>
        <items id="comment">Por ejemplo: Para una dosis de presentación "300 µg/0.3 ml", el valor del denominador de la dosis es "0.3 ml". Para una dosis de presentación de "100 mg/comprimido", el valor del denominador de dosis es "100 mg".</items>
      </items>
    </term_definitions>
    <term_definitions language="fr">
      <items code="at0000">
        <items id="text">Détails du médicament</items>
        <items id="description">Informations détaillées concernant un médicament ou un composant d'un médicament, notamment son dosage, sa forme et les détails relatifs à ses composants spécifiques.</items>
      </items>
      <items code="at0001">
        <items id="text">Produit combiné</items>
        <items id="description">Le médicament ou le composant d'un médicament se compose d’un certain nombre de produits distincts préemballés par le fabricant, par exemple Canesten Combi.</items>
      </items>
      <items code="at0003">
        <items id="text">Date de péremption</items>
        <items id="description">La date et/ou l'heure de péremption du médicament ou d'un composant de médicament, telles qu'indiquées par le fabricant ou la personne chargée de la préparation de la solution.</items>
        <items id="comment">Toute autre forme de date de péremption, telle que la durée depuis la fabrication ou en fonction des conditions de stockage, peut être saisie à l’aide d’un archétype CLUSTER spécifique dans le champ « Détails de la substance » ou ajoutée dans la « Description ».&#xD;
 Par exemple : « 23/05/2017 ».</items>
      </items>
      <items code="at0071">
        <items id="text">Forme</items>
        <items id="description">La formulation ou la présentation du médicament ou d'un composant de médicament.</items>
        <items id="comment">Par exemple : « comprimé », « gélule », « crème », « solution pour perfusion » ou « poudre pour inhalation ». Dans la mesure du possible, il est préférable de coder la forme à l’aide d’une terminologie. Les catalogues de médicaments peuvent établir une distinction entre la forme d’administration « solution injectable » et la forme du produit « poudre pour solution injectable ». La forme enregistrée dépendra du contexte d’utilisation précis, mais la forme d’administration sera probablement utilisée dans la plupart des cas.</items>
      </items>
      <items code="at0080">
        <items id="text">Thérapeutique</items>
        <items id="description">Composant qui, seul ou en association avec un ou plusieurs autres ingrédients, est considéré comme permettant d’exercer l’action visée d’un médicament.</items>
      </items>
      <items code="at0083">
        <items id="text">Adjuvant</items>
        <items id="description">Composant dont la fonction principale est de modifier l'activité d'un principe actif. Un composant adjuvant peut lui-même être ou non thérapeutiquement actif.</items>
      </items>
      <items code="at0084">
        <items id="text">Excipient</items>
        <items id="description">Composant inerte par rapport à l'action visée du médicament.</items>
      </items>
      <items code="at0115">
        <items id="text">Dosage (concentration)</items>
        <items id="description">Le dosage du médicament ou de d'un de composant de médicament, exprimé en concentration.</items>
        <items id="comment">Cet élément est utilisé pour les médicaments liquides ou semi-solides, ou pour les médicaments destinés à être dilués dans un liquide avant leur administration. Par exemple : « 10 mg/ml », « 20 mg/g », « 5 % », « 10 000 SQ-U/ml ». Si le groupe « Concentration (présentation) » est utilisé, cet élément devient redondant.</items>
      </items>
      <items code="at0127">
        <items id="text">Rôle</items>
        <items id="description">Le rôle du médicament ou du composant de médicament au sein d’une préparation.</items>
      </items>
      <items code="at0132">
        <items id="text">Nom</items>
        <items id="description">Le nom du médicament ou du composant de médicament.</items>
        <items id="comment">Par exemple : « Zinacef 750 mg en poudre » ou « céfuroxime ». Cet élément doit être codé si possible, en utilisant par exemple RxNorm, DM+D, la terminologie australienne des médicaments ou FEST. L’utilisation de cet élément varie en fonction du contexte. Cet élément peut être omis lorsque le nom du médicament est consigné dans l’archétype parent INSTRUCTION ou ACTION, et que cet archétype est à utiliser uniquement pour enregistrer que la forme doit être ou était « liquide ».</items>
      </items>
      <items code="at0133">
        <items id="text">Description</items>
        <items id="description">Description narrative du médicament ou d’un composant de médicament lorsqu’il n’est pas possible de le décrire de manière exhaustive à l’aide d’éléments structurés.</items>
      </items>
      <items code="at0138">
        <items id="text">Constituant</items>
        <items id="description">Informations détaillées sur un ingrédient ou un produit utilisé pour composer un conditionnement mixte, une préparation ou une perfusion.</items>
        <items id="comment">Cet emplacement est destiné à être utilisé pour ajouter des détails sur les constituants du médicament ou d’un composant de médicament, à l’aide d’instances imbriquées de cet archétype. Cela n’est généralement pas nécessaire, sauf lorsqu’il s’agit de décrire un mélange.</items>
      </items>
      <items code="at0139">
        <items id="text">Quantité</items>
        <items id="description">La quantité de médicament ou de composant de médicament.</items>
        <items id="comment">Par exemple : « 1 ml », « 1,5 mg », « 1 000 ml ».</items>
      </items>
      <items code="at0141">
        <items id="text">Informations structurées</items>
        <items id="description">Détails supplémentaires sur le médicament ou sur un composant de médicament.</items>
        <items id="comment">Par exemple : des informations détaillées sur la classe de médicaments ou les voies d'administration prévues, ou encore des informations supplémentaires concernant la date de péremption.</items>
      </items>
      <items code="at0142">
        <items id="text">Catégorie</items>
        <items id="description">La catégorie du médicament ou du composant de médicament, en ce qui concerne sa fabrication ou sa préparation, ainsi que le nombre d'ingrédients.</items>
        <items id="comment">Par exemple : « Paracétamol/codéine » est un produit à plusieurs ingrédients, tandis que « Morphine 60 mg + Halopéridol 2 mg + Midazolam 5 mg » est un mélange ad hoc, dont la composition est entièrement précisée dans la prescription.</items>
      </items>
      <items code="at0143">
        <items id="text">Mélange ad hoc</items>
        <items id="description">Le médicament ou le composant de médicament est constitué d’un mélange d’ingrédients spécifiés dans la prescription. Ceux-ci sont généralement préparés par le personnel de la pharmacie ou du service afin d’être adaptés à chaque patient.</items>
      </items>
      <items code="at0144">
        <items id="text">Produit à plusieurs ingrédients</items>
        <items id="description">Le médicament ou le composant de médicament se compose d’un certain nombre de principes actifs qui sont pré-associés par le fabricant sous une forme unique, telle qu’un comprimé, une crème ou une poudre, par exemple le paracétamol/codéine.</items>
      </items>
      <items code="at0145">
        <items id="text">Produit à ingrédient unique</items>
        <items id="description">Le médicament ou le composant de médicament est un produit manufacturé contenant un seul principe actif.</items>
      </items>
      <items code="at0146">
        <items id="text">Ingrédient</items>
        <items id="description">Le médicament ou le composant de médicament est un ingrédient individuel de ce médicament. Ce terme est utilisé lorsque l’archétype est imbriqué dans une instance parente de lui-même, afin de décrire les ingrédients individuels d’un médicament.</items>
      </items>
      <items code="at0148">
        <items id="text">Autre dosage</items>
        <items id="description">Une représentation équivalente de la quantité du médicament ou du composant de médicament.</items>
        <items id="comment">Par exemple : pour un médicament dont le dosage est de « 5 mg/ml » et dont la quantité est de « 1 ml », la valeur enregistrée dans cet élément de données serait « 5 mg ».</items>
      </items>
      <items code="at0150">
        <items id="text">Numéro de lot</items>
        <items id="description">Identifiant attribué au lot de fabrication par le fabricant au cours du processus de fabrication.</items>
      </items>
      <items code="at0151">
        <items id="text">Fabricant</items>
        <items id="description">Le fabricant du médicament ou du composant de médicament.</items>
        <items id="comment">Par exemple : « Abbott ».</items>
      </items>
      <items code="at0152">
        <items id="text">Dosage (présentation)</items>
        <items id="description">La concentration du médicament ou de du composant de médicament, exprimée sous forme de rapport.</items>
        <items id="comment">Dans certains cas, comme pour les médicaments liquides ou semi-solides, le dénominateur du rapport de dosage est une grandeur physique, par exemple 2 mg/5 ml. Dans certains de ces cas, le dénominateur reflète également le volume réel du composant : 5 ml dans l’exemple précédent. Dans ce cas, le « dosage (concentration) » serait de 0,4 mg/ml. Dans d’autres cas, lorsque la concentration comporte un dénominateur qui n’est pas une grandeur physique, par exemple 4 mg/comprimé, le dénominateur est exprimé sous la forme d’une valeur unitaire « 1 » avec l’unité « comprimé ». Ce choix a été fait afin de s’aligner sur l’approche adoptée par la norme ISO IDMP pour les catalogues de médicaments. Si l’élément « Concentration » est utilisé, ce groupe d’éléments devient redondant.</items>
      </items>
      <items code="at0153">
        <items id="text">Numérateur de la concentration</items>
        <items id="description">Le numérateur de la fraction indiquant la concentration.</items>
        <items id="comment">Par exemple : pour une concentration de « 300 µg/0,3 ml », le numérateur de la concentration est « 300 µg ». Pour une concentration de « 100 mg/comprimé », la valeur du numérateur de la concentration est « 100 mg ».</items>
      </items>
      <items code="at0157">
        <items id="text">Dénominateur de la concentration</items>
        <items id="description">Le dénominateur de la fraction de concentration.</items>
        <items id="comment">Par exemple : pour un dosage de « 300 µg/0,3 ml », la valeur du dénominateur du dosage est « 0,3 ml ». Pour un dosage de « 100 mg/comprimé », la valeur du dénominateur du dosage est « 1 comprimé ».</items>
      </items>
    </term_definitions>
  </ontology>
</archetype>
